Culture and identification of <i>Borrelia </i>spirochetes in human vaginal and seminal secretions

Marianne J. Middelveen; Jennie Burke; Eva Sapi; Cheryl Bandoski; Katherine R. Filush; Yean Wang; Agustin Franco; Arun Timmaraju; Hilary A. Schlinger; Peter J. Mayne; Raphael B. Stricker

doi:10.12688/f1000research.5778.1

Home Browse Culture and identification of Borrelia spirochetes in human vaginal...

ALL Metrics

Views

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions

[version 1; peer review: 1 not approved]

Marianne J. Middelveen¹, Jennie Burke², Eva Sapi³, [...] Cheryl Bandoski³, Katherine R. Filush³, Yean Wang², Agustin Franco², Arun Timmaraju³, Hilary A. Schlinger¹, Peter J. Mayne¹, Raphael B. Stricker¹

Marianne J. Middelveen¹, Jennie Burke², [...] Eva Sapi³, Cheryl Bandoski³, Katherine R. Filush³, Yean Wang², Agustin Franco², Arun Timmaraju³, Hilary A. Schlinger¹, Peter J. Mayne¹, Raphael B. Stricker¹

PUBLISHED 18 Dec 2014

Author details Author details

¹ International Lyme and Associated Diseases Society, Bethesda, MD, 20827-1461, USA
² Australian Biologics, Sydney, NSW 2000, Australia
³ Department of Biology and Environmental Science, University of New Haven, West Haven, CT, 06516, USA

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Background: Recent reports indicate that more than 300,000 cases of Lyme disease are diagnosed yearly in the USA. Preliminary clinical, epidemiological and immunological studies suggest that infection with the Lyme disease spirochete Borrelia burgdorferi (Bb) could be transferred from person to person via intimate human contact without a tick vector. Detecting viable Borrelia spirochetes in vaginal and seminal secretions would provide evidence to support this hypothesis.
Methods: Patients with and without a history of Lyme disease were selected for the study after informed consent was obtained. Serological testing for Bb was performed on all subjects. Semen or vaginal secretions were inoculated into BSK-H medium and cultured for four weeks. Examination of genital cultures and culture concentrates for the presence of spirochetes was performed using light and darkfield microscopy, and spirochete concentrates were subjected to Dieterle silver staining, anti-Bb immunohistochemical staining, molecular hybridization and PCR analysis for further characterization. Immunohistochemical and molecular testing was performed in three independent laboratories. Positive and negative controls were included in all experiments.
Results: Control subjects who were asymptomatic and seronegative for Bb had no detectable spirochetes in genital secretions by PCR analysis. In contrast, spirochetes were observed in cultures of genital secretions from 11 of 13 subjects diagnosed with Lyme disease, and motile spirochetes were detected in genital culture concentrates from 12 of 13 Lyme disease patients using light and darkfield microscopy. Morphological features of spirochetes were confirmed by Dieterle silver staining and immunohistochemical staining of culture concentrates. Molecular hybridization and PCR testing confirmed that the spirochetes isolated from semen and vaginal secretions were strains of Borrelia, and all cultures were negative for treponemal spirochetes. PCR sequencing of cultured spirochetes from three couples having unprotected sex indicated that two couples had identical strains of Bb sensu stricto in their semen and vaginal secretions, while the third couple had identical strains of B. hermsii detected in their genital secretions.
Conclusions: The culture of viable Borrelia spirochetes in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person.

Keywords

Lyme borreliosis, chronic Lyme disease, Borrelia burgdorferi, spirochetes, sexual transmission.

Corresponding author: Raphael B. Stricker

Competing interests: The authors have no competing interests to declare. Preliminary results of the study were presented at the Western Regional Meeting of the American Federation for Medical Research, Carmel, CA, on January 25, 2014, and published in abstract form (<i>J Invest Med</i> 2014;62:280–1).

Grant information: Supported in part by a grant to MJM from the Lindorf Family Foundation, Newark, OH.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2014 Middelveen MJ et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

How to cite: Middelveen MJ, Burke J, Sapi E et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions [version 1; peer review: 1 not approved]. F1000Research 2014, 3:309 (https://doi.org/10.12688/f1000research.5778.1) First published: 18 Dec 2014, 3:309 (https://doi.org/10.12688/f1000research.5778.1) Latest published: 27 Apr 2015, 3:309 (https://doi.org/10.12688/f1000research.5778.3)

Introduction

Lyme disease is the most common human tick-borne disease in the world today (Stricker & Johnson, 2014). It is transmitted by Ixodes ticks and is caused by the spirochete Borrelia burgdorferi (Bb) (Burgdorfer et al., 1982). Bb is phylogenetically related to the spirochetal agent of syphilis, Treponema pallidum (Gupta et al., 2013). T. pallidum is transmitted sexually between partners through contact of mucosal membranes, gaining access to the bloodstream through microabrasions and then disseminating systemically (Ho & Lukehart, 2011). The close phylogenic relationship of Bb to T. pallidum suggests that this mode of transmission might be possible for Bb.

In addition to theoretical considerations, evidence for non-vector transmission of Bb is based on animal models. Proof of contact transmission of Bb – without involvement of an arthropod vector – was established by two studies in mice. Burgess et al. (1986) caged uninfected deer mice with experimentally-infected deer mice and demonstrated transmission of Bb by seroconversion of contact-exposed mice from negative to positive and by the isolation of Bb from the blood of one contact-exposed mouse 42 days after initial contact. A study by Wright & Nielsen (1990) demonstrated that white-footed mice were susceptible to oral infection and transmitted infection to each other through direct contact. Furthermore, sexual transmission of Bb has been proposed in a canine model. Bb was transmitted to uninfected female dogs in estrus via semen by natural breeding with male dogs infected experimentally with Bb (Gustafson, 1993). Successful transmission of infection from male dogs to female dogs was shown by seroconversion of female dogs from negative to positive as well as the detection of Bb DNA in the tissue of fetuses from resulting pregnancies. If contact transmission of Bb occurs in mice and sexual transfer occurs in dogs, it is not unreasonable to postulate similar routes of infection in humans.

We sought to determine if viable Borrelia spirochetes could be recovered from human vaginal and seminal secretions, an important first step to investigate whether sexual transmission of these spirochetes among humans is possible.

Materials and methods

1. Research subject selection

Control subjects who were asymptomatic without a history of Lyme disease and patients with a history of Lyme disease were recruited for the study after written informed consent to collect and publish their data was obtained. Approval for sample collection was obtained from the Western Institutional Review Board, Olympia, WA (WIRB^® #20141439). Further approval for sample testing was obtained from the Institutional Review Board of the University of New Haven, West Haven, CT. Serological testing of all participants was performed by IGeneX Reference Laboratories, Palo Alto, CA. Patients were considered positive for Lyme disease if they were serologically positive or if they had musculoskeletal, neurocognitive or cardiac symptoms clinically consistent with a Lyme disease diagnosis. None of the patients were taking antibiotics at the time of testing.

2. Borrelia cultures

Borrelia spirochetes were cultured as previously described (Bankhead & Chaconas, 2007; Middelveen et al., 2013b; Middelveen et al., 2014a). The inoculum for blood culture was prepared as follows: 10 milliliters of whole blood was collected by sterile venipuncture from each patient. Samples sat at room temperature for 10 to 15 minutes allowing clotting to occur. Red blood cells (RBCs) were separated by low speed centrifugation. Barbour–Stoner–Kelly H (BSK-H) complete medium was used for cultures with the addition of 6% rabbit serum (Sigma Aldrich, #B8291) and the following antibiotics: phosphomycin (0.02 mg/ml), rifampicin (0.05 mg/ml), and amphotericin B (2.5 µg/ml) (Sigma Aldrich).

The culture medium described above was inoculated for blood culture with the spun serum containing white blood cells and some RBCs, and for genital culture with either ejaculated semen or vaginal secretions collected by intravaginal swabbing with a sterile cotton-tipped swab. Blood and genital cultures were incubated at 32°C in an Oxoid anaerobic jar (Thermo Scientific) containing an AnaeroGen sachet (Thermo Scientific) to provide an anaerobic environment. Cultures were incubated for four weeks and checked weekly by light and/or darkfield microscopy for visible motile spirochetes.

All cultures were processed for microscopic imaging and PCR by centrifuging the culture fluid at 15,000 g for 20 minutes to concentrate spirochetes. The supernatant was discarded and the pellet retained.

3. Dieterle silver staining

Dieterle silver staining was performed using two fixation methods. In the standard method, formalin-fixed, paraffin-embedded pellets were sectioned and stained with Dieterle silver stain as previously described (Aberer & Duray, 1991; Middelveen et al., 2013a). In the newer method, culture fluid was spread and dried on a SuperFrost™ Plus microscope slide (Fisher Scientific) and fixed by incubating the slide in acetone for 10 minutes at -20°C, as previously described (Sapi et al., 2013). Dieterle silver staining was performed on the acetone-fixed slide.

4. Anti-Bb immunostaining

A. McClain Laboratories. Blood and genital culture pellets were processed for special staining at McClain Laboratories LLC, Smithtown, NY. Formalin-fixed, paraffin-embedded pellets were sectioned and stained with Dieterle silver stain or anti-Bb immunostains for spirochete detection, as previously described (Middelveen et al., 2013a; Middelveen et al., 2014a). In brief, immunostaining was performed using an unconjugated rabbit anti-Bb polyclonal antibody (Abcam ab20950), incubated with an alkaline phosphatase probe (Biocare Medical #UP536L), followed by a chromogen substrate (Biocare Medical #FR805CHC), and counterstained with hematoxylin. Positive and negative controls were prepared for comparison purposes with liver sections from Bb-inoculated mice and uninfected mice followed by Dieterle and immunostaining. Culture pellets from mixed Gram-positive bacteria and mixed Gram-negative bacteria were also prepared for comparison purposes as negative controls to exclude cross-reactivity with commonly encountered microorganisms. Staining was titrated to determine optimal antibody dilutions to achieve positive staining of spirochetes while minimizing background staining (Middelveen et al., 2013a; Middelveen et al., 2014a).

B. University of New Haven. Samples were processed for Bb immunostaining as previously described (Sapi et al., 2013). Culture fluid was spread and dried on a SuperFrost™ Plus microscope slide (Fisher Scientific) and fixed by incubating the slide in acetone for 10 minutes at -20°C. Dried, fixed culture fluid was submerged under 100 μl of polyclonal FITC-labeled rabbit anti-Bb antibody (Thermo Scientific #PA-1-73005) diluted 1:50 in 1× PBS buffer with 1% BSA (Sigma Aldrich #A9418). For negative controls, the antibody was omitted and replaced with normal rabbit serum. The slides were then incubated for 1 hour at 37°C in a humidified chamber, washed with 1× PBS for 5 minutes at room temperature, rinsed twice in double distilled water and dried in a laminar air-flow hood for 10 minutes. The slides were mounted with Vectashield mounting medium with DAPI counterstain (Vector Labs) and viewed with fluorescent microscopy at 400× magnification with a Leica DM2500 microscope (Sapi et al., 2013).

5. Molecular hybridization using Bb DNA probe

The Bb molecular beacon DNA probe was generously provided by Dr. Alan MacDonald. Probe FlaB (sequence of 23 mer) was derived from the Bb open reading frame (ORF) BB0147 (approximately 1100 mer) of the flagellin B gene. A nucleotide Basic Local Alignment Search Tool (BLAST) search of the 23 mer sequence disclosed no matches in the human genome or in any other life form other than the Bb sequence of BB0147.

Bb detection with the molecular beacon was performed as previously described (Middelveen et al., 2014a) using the following protocol: paraffin sections were dewaxed by baking at 60°C, then immersed in serial 100% xylene baths followed by serial immersion through baths of 100% ethanol, 90% ethanol, 80% ethanol, and finally in distilled H₂O, and then air-dried. Fixed sections were immersed in 20 μl of the working DNA beacon solution. The sectioned specimen was covered with a layer of plastic cut from a Ziploc^® freezer bag and was heated at 90°C for 10 minutes to denature DNA and RNA. The heat was first reduced to 80°C for 10 minutes, then the slides were removed from heat and allowed to gradually cool to 24°C. The slides were washed in PBS, covered with 30% glycerol and a glass coverslip, then examined under an EPI Fluor microscope. Staining of test specimens was performed alongside staining of positive and negative controls. The positive control was prepared by embedding a known Bb strain in agarose, formalin-fixing the specimen then blocking in paraffin and staining sections as described above.

The specificity of the FlaB probe was validated in studies performed at the University of New Haven (Sapi E., unpublished observation 2014; see Supplemental Figure 1). The FlaB probe hybridized to Bb sensu stricto, yet failed to hybridize with B. afzelii, B. garinii, B. hermsii, Treponema denticola and Escherichia coli. Thus the probe appears to be specific for detection of Bb sensu stricto.

6. PCR of cultures

Blood and genital culture pellets were first dissolved in 200 μl of Qiagen buffer, then forwarded to the University of New Haven, Department of Biology and Environmental Science, West Haven, CT, USA and Australian Biologics, Sydney, NSW, Australia for PCR detection of Borrelia.

A. Australian Biologics. Detection of Borrelia by PCR was performed as previously described (Mayne et al., 2012) using the Eco™ Real-Time PCR system with primers targeted to the genes encoding 16S rRNA (Borrelia), flA (T. denticola) and fliG1 (T. pallidum) and analyzed with the software version 3.0.16.0. DNA was extracted from the dissolved culture pellets using the QIAamp DNA Mini Kit (Qiagen) and 20 μl were used for each reaction. The thermal profile involved incubation for 2 minutes at 50°C, polymerase activation for 10 minutes at 95°C then PCR cycling for 40 cycles of 10 seconds at 95°C dropping to 60°C sustained for 45 seconds. All samples were run in duplicate with positive and negative controls. Positive controls were genomic DNA samples from B. burgdorferi, B. garinii, and B. afzelii (Amplirun DNA/RNA amplification controls, Vircell S.L, Granada, Spain). Negative controls were samples of non-template DNA in molecular-grade water. The magnitude of the PCR signal generated (∆R) for each sample was interpreted as positive or negative compared to positive and negative controls.

In samples with sufficient DNA for sequencing, endpoint PCR amplification and Sanger sequencing of the Borrelia gene target from cultures was followed by BLAST comparison with known Borrelia sequences, as previously described (Mayne et al., 2012).

B. University of New Haven. DNA samples were extracted from blood, vaginal or seminal cultures by lysing cells overnight in 180 µl tissue lysis buffer (Qiagen) and 20 µl Proteinase K (Qiagen) at 56°C in a shaking water bath followed by phenol:chloroform extraction the next day. The DNA was resuspended in 50–100 µl 1×TE buffer.

A published TaqMan assay targeting a 139-bp fragment of the gene encoding the Borrelia 16S rRNA was used for the detection of Borrelia in DNA extracted from patient samples (O’Rourke et al., 2013). All reactions were carried out at a final volume of 20 µl and consisted of 900 nM of each primer, 200 nM of probe, and 10 µl of 2× TaqMan Universal PCR Master Mix (Applied Biosystems) and 1 nanogram of DNA. Amplifications were carried out on a CFX96 Real-Time System (Bio-Rad), and cycling conditions consisted of 50°C for 2 minutes, 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 60 seconds. Fluorescent signals were recorded with CFX96 Real-Time software and Cq threshold was set automatically. The reactions were performed in triplicate with positive and negative controls.

Nested PCR primers for the genes encoding the Borrelia 16S rRNA, fla and pyrG loci were used as previously described (Clark et al., 2013; Margos et al., 2010; Sapi et al., 2013). Reactions were carried out in a final volume of 50 µl using 10 µl template DNA. Final concentrations were 2× Buffer B (Promega), 2 mM MgCl₂, 0.4 mM dNTP mix, 2 µM of each primer, and 2.5 U Taq polymerase (Invitrogen). “Outer” primers were used in the first reaction. “Inner” primers were used for the nested reaction, in which 1 µl of PCR product from the first reaction was used as template for the second. Cycling parameters were as follows: 94°C for 5 minutes followed by 40 cycles of denaturation at 94°C for 1 minute, annealing for 1 minute (temperature based on the primer set used), and extension at 72°C for 1 minute, with a final extension step at 72°C for 5 minutes. PCR products were visualized on 1–2% agarose gels. Sanger sequencing was used for gene analysis, as previously described (Margos et al., 2010).

Results

1. Patient data

All patient data are shown in Table 1. The control group included four asymptomatic patients (two males and two females). All four were seronegative for Bb.

Table 1. Patient Data.

Patients 6 & 7 (*), 8 & 9 (**), 10 & 11 (†), and 12 & 13 (††) are sexual partners. Patients 8 and 11 were seronegative but clinically diagnosed with Lyme disease.

Control	Sex	Age	Serology
1 (M)	male	63	negative
2 (M)	male	53	negative
3 (F)	female	58	negative
4 (F)	female	43	negative

Patient	Sex	Age	Serology
1 (F)	female	56	equivocal
2 (M)	male	45	positive
3 (M)	male	35	positive
4 (F)	female	66	positive
5 (F)	female	27	positive
6 (M)*	male	63	positive
7 (F)*	female	53	positive
8 (M)**	male	42	negative
9 (F)**	female	40	positive
10 (M)†	male	56	positive
11 (F)†	female	54	negative
12 (M)††	male	65	positive
13 (F)††	female	54	positive

The patient group included six male subjects and seven female subjects, including four pairs of partners (Patients 6 and 7, 8 and 9, 10 and 11, and 12 and 13, respectively). Eleven of the 13 patients selected for the study were serologically positive for Lyme disease. Patient 1 was serologically equivocal and patient 8 was seronegative, although Bb plasmid DNA was detected in whole blood and serum from this patient.

2. Light and darkfield microscopy

Blood cultures from 11 patients were incubated for four weeks and checked weekly for spirochete growth using light and darkfield microscopy. Motile spirochetes and/or motile spherules were observed in the culture fluid from all 11 patients after four weeks (Table 2). Genital cultures from the four controls were incubated for four weeks. None of the control cultures contained visible spirochetes, and the cultures were sent for PCR testing. Genital cultures from the 11 patients were incubated for four weeks and checked weekly. Motile spirochetes were observed in the culture fluid from all 11 patients after four weeks (Figure 1A). See Dataset, data file 1.

Table 2. Microscopy results from fresh blood and genital culture fluid.

See Dataset, data file 1. ND, not done.

Patient number	Microscopy – fresh blood culture fluid	Microscopy – fresh genital culture fluid
1 (F)	motile spherules	vaginal – motile spirochetes
2 (M)	ND	seminal – ND
3 (M)	ND	seminal – ND
4 (F)	motile spherules	vaginal – motile spherules and spirochetes
5 (F)	motile spherules	vaginal – motile spirochetes, some yeast cells
6 (M)	motile spirochetes and spherules	seminal – motile spirochetes
7 (F)	motile spirochetes and spherules	vaginal – motile spherules and spirochetes
8 (M)	motile spherules	seminal – motile spirochetes
9 (F)	motile spherules	vaginal – motile spirochetes
10 (M)	motile spherules	seminal – motile spherules/ spirochetes
11 (F)	motile spherules	vaginal – motile spherules/ spirochetes
12 (M)	motile spherules	seminal – motile spherules/ spirochetes
13 (F)	motile spherules	vaginal – motile spherules/ spirochetes

Figure 1.

A: Darkfield image of genital culture from Patient 1. Note numerous spirochetes. 400× magnification. See Dataset, data file 1. B: Dieterle silver stain of genital culture from Patient 12. Note darkly staining spirochete. Formalin fixed slide, 400× magnification. See Dataset, data file 2. C: Semen sample from Patient 10 showing B. burgdorferi spirochetes (left) and sperm cell (right). Dieterle silver stain of acetone fixed slide, 1000× magnification. See Dataset, data file 2.

Most genital cultures grew very well and contained abundant spirochetes, but some blood cultures contained few spirochetes. Therefore, to better document the presence of spirochetes in culture, the culture fluid was concentrated into pellets by centrifugation (Table 3). Spirochetes and/or spherules were detected by sectioning and special staining of paraffin blocked pellets in all the patient blood and genital cultures concentrated by centrifugation, except for blood and genital culture pellets from Patient 1 that were lost during paraffin blocking (Table 3). Control genital culture samples were sent directly for PCR testing and were not subjected to light and darkfield microscopy.

Table 3. Microscopy results and Dieterle silver staining of genital culture concentrates.

See Dataset, data file 2.

Patient number	Microscopy – genital culture pellet	Dieterle silver stain – genital culture pellet
1 (F)	pellet lost	pellet lost
2 (M)	seminal – spherules/ spirochetes	seminal – spherules/ spirochetes
3 (M)	seminal – spirochetes	seminal – spherules/ spirochetes
4 (F)	vaginal – spirochetes	vaginal – spherules
5 (F)	vaginal – spirochetes, some yeast cells	vaginal – spherules
6 (M)	seminal – spirochetes	seminal – spherules/ spirochetes
7 (F)	vaginal – spirochetes	vaginal – spherules/ spirochetes
8 (M)	seminal – spirochetes	seminal – spherules/ spirochetes
9 (F)	vaginal – spherules/ spirochetes	vaginal – spherules
10 (M)	seminal – spirochetes	seminal – spherules/ spirochetes
11 (F)	vaginal – spirochetes	vaginal – spherules/ spirochetes
12 (M)	seminal – spirochetes	seminal – spherules/ spirochetes
13 (F)	vaginal – spirochetes	vaginal – spherules/ spirochetes

3. Immunohistochemistry

A. Dieterle silver staining. Using standard Dieterle staining, spherules and/or spirochetal forms were visible in all patient genital cultures (Figure 1B). Spirochetes were detected in all patient genital culture pellets except for Patient 1, whose pellet was lost during processing (Table 3). Using the newer fixation method, spirochetes and sperm cells were visible in semen samples and showed distinct morphology (Figure 1C). Sperm cells are known to stain with silver stains (Pathak et al., 1979; Schmid et al., 1983). Sperm cells were seen in all semen samples except for Patients 2 and 6, who had vasectomies (data not shown). Since control genital cultures had no visible spirochetes, the control samples were sent directly for PCR testing and were not subjected to Dieterle silver staining. See Dataset, data file 2.

B. Anti-Bb immunostaining.

I. Culture fluid – University of New Haven

Genital culture fluid from Patient 1 was fixed on a SuperFrost™ Plus microscope slide and was stained with FITC-labelled polyclonal anti-Bb antibody. Staining was strongly positive, revealing well-defined spirochetes morphologically consistent with Bb (Figure 2A). The polyclonal antibody was not reactive to T. denticola (data not shown).

II. Culture pellets – McClain Laboratories

Anti-Bb immunostaining was positive for all genital cultures except for Patient 1, whose pellet was lost during processing (Table 4). Immunostaining revealed both spiral and globular Bb forms (Figure 2B). Since control genital cultures had no visible spirochetes, the control samples were sent directly for PCR testing and were not subjected to immunostaining. See Dataset, data file 3.

Table 4. Results of B. burgdorferi immunostaining and FlaB molecular hybridization in genital culture concentrates.

See Dataset, data files 3 and 4. ND, not done.

Patient number	Bb immunostaining - genital culture pellet	FlaB hybridization – genital culture pellet
1 (F)	pellet lost*	pellet lost
2 (M)	seminal – positive	seminal – positive
3 (M)	seminal – positive	seminal – positive
4 (F)	vaginal – positive	vaginal – positive
5 (F)	vaginal – positive	vaginal – positive
6 (M)	seminal – positive	seminal – positive
7 (F)	vaginal – positive	vaginal – positive
8 (M)	seminal – positive	seminal – positive
9 (F)	vaginal – positive	vaginal – positive
10 (M)	seminal – positive	ND
11 (F)	vaginal – positive	ND
12 (M)	seminal – positive	ND
13 (F)	vaginal – positive	ND

*Positive Bb immunostaining of genital culture fluid. See Results section.

Figure 2.

A: B. burgdorferi immunostaining of vaginal culture from Patient 1. Note intensely staining spiral and round forms in culture. 400× magnification. B: B. burgdorferi immunostaining of seminal culture from Patient 6. Note intensely staining spiral and round forms in culture. 400× magnification. See Dataset, data file 3.

4. Molecular hybridization

Hybridization with the Fla B probe was positive for genital culture pellets from Patients 2–9 (Table 4). The culture pellet from Patient 1 was lost during processing. The molecular probe showed intense staining in vaginal secretions and less intense staining in semen samples (Figure 3A and 3B). See Dataset, data file 4.

Figure 3.

A: Molecular hybridization of B. burgdorferi-specific FlaB probe with seminal culture from Patient 6. Note intensely staining spiral and round forms in culture. 400× magnification. B: Molecular hybridization of B. burgdorferi-specific FlaB probe with vaginal culture from Patient 7. Note intensely staining spiral and round forms in culture. 400× magnification. See Dataset, data file 4.

5. PCR testing

A. Australian Biologics. Borrelia 16S rRNA sequence was not detected by real-time PCR in any of the control genital culture pellets. In contrast, Borrelia 16S rRNA sequence was detected in genital culture pellets from 11 of 13 patients (Table 5A). Patient 2 had equivocal test results and Patient 3 had negative test results in seminal cultures. See Dataset, data file 5. Real-time PCR failed to detect treponemal gene sequences in any of the control or patient genital culture pellets. See Dataset, data file 5a. The 16S rRNA isolates from six patients were sequenced and subjected to BLAST analysis (see below).

B. University of New Haven. PCR testing using the TaqMan assay for Borrelia 16S rRNA sequence was positive in blood culture pellets from seven of nine patients tested (Table 5B). Patients 1 and 5 had negative results in blood culture pellets using the TaqMan assay, but both were positive by nested PCR for the pyrG gene. In addition, nested PCR targeting the fla gene was performed on blood culture pellets from Patients 2, 3 and 4, and nested PCR targeting the 16S rRNA gene was performed on the blood culture pellet from Patient 6. The samples were positive, and sequencing revealed 99–100% homology with Bb sensu stricto strain B-31 (Table 5B). See Dataset, data file 7.

Table 5. A: Real time PCR testing of genital culture concentrates performed by Australian Biologics. ND, not done. See Dataset, data file 5. B: Real time and nested PCR testing of blood and genital culture concentrates performed by University of New Haven. See Dataset, data file 7. ND, not done.

Table 5A: Real-time PCR – Australian Biologics.

Control number	Genital culture – Real- time Borrelia PCR	Genital culture – Real- time T. pallidum PCR	Genital culture – Real- time T. denticola PCR
1 (M)
seminal	Negative	Negative	Negative
2 (M)
seminal	Negative	Negative	Negative
3 (F)
vaginal	Negative	Negative	Negative
4 (F)
vaginal	Negative	Negative	Negative

Patient # sample	Genital culture – Real- *time Borrelia* PCR**	Genital culture – Real- *time T. pallidum* PCR**	Genital culture – Real- *time T. denticola* PCR**
1 (F) vaginal	positive (sequenced 99% match B-31)	negative	negative
2 (M) seminal	equivocal	negative	negative
3 (M) seminal	negative	negative	negative
4 (F) vaginal	positive	negative	negative
5 (F) vaginal	positive	negative	negative
6 (M) seminal	positive (sequenced 100% match B-31)	negative	negative
7 (F) vaginal	positive (sequenced 98% match B-31)	negative	negative
8 (M) seminal	positive	negative	negative
9 (F) vaginal	positive	negative	negative
10 (M) seminal	positive (sequenced 100% match YOR)	ND	ND
11 (F) vaginal	positive (sequenced 100% match YOR)	ND	ND
12 (M)
seminal	positive	ND	ND
13 (F)
vaginal	positive (sequenced 100% match B-31)	ND	ND

Table 5B. PCR – University of New Haven.

Control number	Blood culture	Genital culture – 16S rRNA Taq Man PCR	Genital culture – Nested PCR
1 (M)	ND	Negative	pyrG negative, fla negative
2 (M)	ND	Negative	pyrG negative, fla negative
3 (F)	ND	Negative	pyrG negative, fla negative
4 (F)	ND	Negative	pyrG negative, fla negative

Patient number	Blood culture – primers with positive detection	Genital culture – primers with positive detection
1 (F)	pyrG	16S rRNA Taq Man
2 (M)	16S rRNA Taq Man, fla (sequenced, 100% match B-31)	16S rRNA Taq Man
3 (M)	16S rRNA Taq Man, fla (sequenced, 100% match B-31)	16S rRNA Taq Man, fla, 16S rRNA (sequenced, 99% match B-31)
4 (F)	16S rRNA Taq Man, fla (sequenced, 99% match B-31)	16S rRNA Taq Man
5 (F)	pyrG	16S rRNA Taq Man
6 (M)	16S rRNA Taq Man 16S rRNA (sequenced, 99% match B31)	16S rRNA
7 (F)	16S rRNA Taq Man, pyrG	16S rRNA Taq Man, 16S rRNA, fla
8 (M)	16S rRNA Taq Man	16S rRNA Taq Man
9 (F)	16S rRNA Taq Man	16S rRNA Taq Man
10 (M)	ND	ND
11 (F)	ND	ND
12 (M)	ND	pyrG (sequenced, 99% match B-31)
13 (F)	ND	ND

PCR testing using the TaqMan assay for Borrelia 16S rRNA sequence was negative in all four control genital culture pellets, and nested PCR targeting the pyrG and fla genes was negative in all four control samples, confirming the results of the TaqMan assay (Table 5B). In contrast, eight of nine patients were positive for TaqMan 16S rRNA sequence in the genital culture pellets. Patient 6 was negative using the TaqMan assay for 16S rRNA sequence but positive using nested PCR targeting a different portion of the 16S rRNA gene (Table 5B). Nested PCR targeting the fla gene (Patient 3) and the 16S rRNA gene (Patients 3 and 7) was also performed on genital culture pellets and was positive in those patients, confirming the results of the TaqMan assay. Patient 12 had positive PCR targeting the pyrG gene with confirmatory sequencing (see below).

6. Sequencing of Borrelia detected in blood and genital cultures

PCR isolates of the vaginal culture from Patient 1 (Australian Biologics) and the seminal culture from Patient 3 (University of New Haven) were subjected to Sanger sequencing and BLAST analysis and showed 97–99% homology with Bb sensu stricto strain B-31 (Table 5A and Table 5B). See Datasets, data files 6 and 7. PCR isolates of blood cultures from Patients 2, 3, 4 and 6 were subjected to Sanger sequencing and BLAST analysis at University of New Haven and showed 99–100% homology with Bb sensu stricto strain B-31 (Table 5B). See Dataset, data file 7.

PCR isolates of genital cultures from three couples having unprotected sex (Patients 6-7, 10-11 and 12-13) were subjected to Sanger sequencing and BLAST analysis. Patients 6, 7, 10, 11 and 13 had sequencing done at Australian Biologics, while Patient 12 had sequencing done at University of New Haven. Sequencing revealed that the first and third couples had Borrelia strains that matched Bb sensu stricto strain B-31 (Table 6). In contrast, the second couple had PCR sequences that matched B. hermsii strain YOR. Thus the Borrelia strain shared by this couple differed significantly from the strains identified in the other couples. See Dataset, data file 6.

Dataset 1.Raw data of Borrelia spirochetes in human vaginal and seminal secretions.

The dataset contains data files 1, 2, 3, 4, 5, 5a, 6 and 7. Detailed legends for each files can be found in the text file provided.

Table 6. Comparison of seminal and vaginal Borrelia gene sequences using BLAST analysis.

Sequencing for Patients 6, 7, 10, 11 and 13 was done at Australian Biologics. Sequencing for Patient 12 was done at University of New Haven. See Dataset, data file 6.

Patient	Description	Maximum Score	Total Score	Query Cover	E Value	Reference Strain Match
6 (M)	Bb sensu stricto (B31)	230	230	84%	3e-57	100%
7 (F)	Bb sensu stricto (B31)	224	224	83%	2e-55	98%
10 (M)	B. hermsii (YOR)	32.2	1229	75%	1.5	100%
11 (F)	B. hermsii (YOR)	30.2	599	84%	2.1	100%
12 (M)	Bb sensu stricto (B31)	1218	1218	95%	1e-63	99%
13 (F)	Bb sensu stricto (B31)	97.6	4880	87%	1e-20	100%

Discussion

In this study using standard and published culture, immunohistochemical, molecular hybridization and PCR techniques, we have shown that Borrelia strains are present in semen and vaginal secretions from patients with Lyme disease. Simultaneous testing for treponemal spirochetes was negative in genital secretions of all Lyme disease patients, confirming the specificity of Borrelia detection in these patients. Furthermore we have shown that couples having unprotected sex have virtually identical strains of Borrelia in their genital secretions, suggesting that Borrelia spirochetes might be transmitted from person to person without a tick vector.

As expected, PCR sequencing of cultured Borrelia from semen and vaginal secretions yielded primarily Bb sensu stricto strains, reflecting the North American origin of our study subjects. In addition, PCR sequencing of genital secretions from one couple yielded identical strains of Bb sensu stricto strains in two different laboratories. However, we were surprised to find one couple with identical strains of B. hermsii in their genital secretions. The presence of a distinct Borrelia strain in semen and vaginal secretions from a sexually active couple that differs from strains found in other couples supports the premise of Borrelia transmission via shared genital secretions. The finding is analogous to sharing distinct human immunodeficiency virus (HIV) strains, which is well recognized in sexual partners with HIV/AIDS (Shaw & Hunter, 2012).

Animal models have provided compelling evidence for contact transmission of Bb without a tick vector in mice, ducks, cats and dogs (Burgess et al., 1986; Burgess & Patrican, 1987; Burgess, 1989; Burgess, 1992; Wright & Neilsen, 1990). Bb has been shown to survive in stored semen from dogs, rams and bulls (Kumi-Diaka & Harris, 1995). Furthermore, seminal transmission of Bb has been noted in dogs, as described above (Gustafson, 1993). In contrast, contact transmission of Bb could not be demonstrated in Lewis rats and Syrian golden hamsters (Moody & Barthold, 1991; Woodrum & Oliver, 1999). Technical limitations in the study of these highly inbred rodents may have contributed to the negative results.

While it is not possible to perform controlled sexual transmission studies in humans, several investigators have speculated that this mode of transmission is possible (Bach, 2001; Harvey & Salvato, 2003; Stricker et al., 2004). The suggestion that Bb could be transmitted sexually was initially proposed by Bach in 2001. He observed that sexually active patients had a marked propensity for antibiotic failure and speculated that re-infection occurred by intimate person-to-person contact. Bb DNA was detected by PCR technology in human breast milk, umbilical cord blood, semen and vaginal secretions taken from patients presenting at his practice (Bach, 2001).

The study of a group of chronically ill Bb-seropositive and PCR-positive patients in Houston, Texas – a non-endemic area – provided epidemiological evidence that Lyme disease could spread in the absence of a suitable vector (Harvey & Salvato, 2003). In the absence of infected ticks, intimate person-to-person transfer was implicated as the probable means of transmission (Harvey & Salvato, 2003). A study by Stricker et al. provided clinical and immunological evidence for Bb transmission from partner to partner. In heterosexual seropositive couples with Lyme disease in which only one partner had a documented tick bite, the partner with the documented tick bite tended to have more severe clinical manifestations of the disease and a lower CD57 natural killer (NK) cell level (Stricker et al., 2004). This difference in clinical severity and CD57 NK cell level was not noted in seropositive couples diagnosed with Lyme disease in which both partners had a documented history of tick bite (Stricker et al., 2004). Sexual transfer of Borrelia infection through mucosal contact therefore seems possible in humans. The fact that we have been able to culture motile, actively reproducing, viable spirochetes from human genital secretions reinforces this hypothesis.

Recent reports from the Centers for Disease Control and Prevention (CDC) indicate that more than 300,000 cases of Lyme disease are diagnosed yearly in the USA (CDC, 2013). Sexual transmission of Borrelia may partly explain the large number of annual cases that is almost two times higher than breast cancer and six times higher that HIV/AIDS (Stricker & Johnson, 2014). Recognition of possible sexual transmission of Borrelia in both humans and animals is fundamentally important because of the epidemiological implications. If sexual transmission of Borrelia occurs in both animals and humans, this mode of transmission is a possible means of introducing Borrelia infection into areas not considered endemic and of introducing the spirochete to new reservoirs. Borrelia would also join the list of other spirochetes that are either proven or postulated to be sexually transmitted, including the spirochetal agents of syphilis and leptospirosis (Harrison & Fitzgerald, 1988; Maatouk & Moutran, 2014).

Lyme disease diagnosis is based largely upon serological testing using CDC-sanctioned two-tier surveillance criteria supported by FDA-approved commercial test kits. While most patients in this study did have positive serological test results for Lyme borreliosis, some were considered serologically negative, and the majority of our study subjects did not meet the positive standard as defined by the CDC surveillance criteria (CDC, 2014a). We were able to detect Borrelia spirochetes in the blood and/or genital secretions of all patients who were clinically diagnosed with Lyme disease, demonstrating that the CDC surveillance protocol is inadequate diagnostically. Inadequate diagnostic methodology undoubtedly results in under-reporting of Lyme disease, and at least one group has speculated that this substandard methodology is considered acceptable because Borrelia is not sexually transmitted (Lange & Sayyedi, 2002). In addition, if Borrelia spirochetes were transmitted sexually, then patients with false-negative results may unknowingly spread the infection to sexual partners.

The 2011 CDC case definition for Lyme disease states that a positive Bb culture confirms the diagnosis of the disease (CDC, 2014b). Although culture of Borrelia genital isolates may be a useful diagnostic laboratory methodology in the future, detecting and characterizing cultured Borrelia isolates is not straightforward, and both false-positive and false-negative results could occur. In our experience, human clinical isolates from genital secretions frequently propagate prolifically in culture, but on occasion they do not. In such instances, the culture must be concentrated and specific staining should be conducted to ascertain the presence of spirochetes. Once detected, spirochetes must be characterized genetically for specific identification. PCR is currently the most reliable means for correctly identifying cultured isolates, but even this methodology has drawbacks and limitations (Lange & Sayyedi, 2002; Nolte, 2012).

There are currently no standardized FDA-approved PCR protocols or kits available for Bb detection, so commercial PCR testing constitutes an array of “home brew” assays using different methodologies such as real-time PCR and nested PCR, with various primers targeting different genes, yielding wide differences in sensitivity and specificity (Nolte, 2012; Schmidt, 1997; Yang et al., 2012). False negatives can result because primers may be strain-specific and may not detect all Borrelia genotypes, and fluids such as blood, semen and vaginal secretions may contain substances inhibitory to the PCR process (Lange & Sayyedi, 2002; Nolte, 2012; Yang et al., 2012). The potential for false-positive PCR testing may also arise if there is DNA contamination in the laboratory, and appropriate positive and negative controls must be included in the assay (Nolte, 2012; Lange & Sayyedi, 2002). We experienced differences in primer specificity in our clinical isolates and also found that inhibition occurred, particularly in semen cultures.

Another complicating factor in Borrelia isolation is the morphological variation of the spirochete, which includes spherical, granular or cystic forms. Morphological variants of Bb, some of which are not culturable, are well documented in the medical literature (Barthold et al., 2010; Hodzic et al., 2014; Kurtti et al., 1987; Preac Mursic et al., 1996). These variants may play a role in infection, enabling Bb and other pathogenic spirochetes to evade the immune system (Döpfer et al., 2012; Menten-Dedoyart, 2012; Preac Mursic et al., 1996). Limited Bb growth and non-spiral morphology are thought to be induced by unfavorable environmental conditions (Brorson et al., 2009), and these features appear to be consistent with our observations. We found that Borrelia growth was more vigorous with more long slender morphological variants in cultures of genital secretions compared to cultures of blood, and we speculate that the human circulatory system is a more hostile environment for Borrelia than the human reproductive system.

Several questions have been raised about the likelihood of Borrelia sexual transmission (Craig, 2014). First, according to the CDC surveillance system Lyme disease occurs most commonly in children and older adults. However, the CDC surveillance system only captures about 10% of Lyme disease patients, and the other 90% may have a different demographic distribution consistent with sexual transmission, as shown in a recent study from Australia (Mayne, 2015). Second, while sexually transmitted diseases like herpes simplex virus (HSV) and gonorrhea show an urban predominance, Lyme disease has a more rural distribution (Craig, 2014). However, Lyme disease is acquired in more ways than HSV and gonorrhea, and the rate of sexual transmission is unknown at present. Thus the epidemiology of Lyme disease may differ from other sexually transmitted diseases based on these undefined variables. Third, the transmission of HIV can be traced from one sex partner to another using HIV strain typing. Based on our study, a similar transmission pattern using Borrelia strain typing may be seen once larger studies are performed among couples having unprotected sex. In summary, sexual transmission of Borrelia is plausible in light of our limited knowledge about the risk of acquiring Lyme disease.

In conclusion, we have shown that Borrelia spirochetes are present in semen and vaginal secretions of patients with Lyme disease. Furthermore, virtually identical strains of Borrelia are present in couples having unprotected sex, suggesting that transmission via intimate contact without a tick vector may occur. The epidemiology and clinical risk of Borrelia sexual transmission remain to be determined.

Data availability

F1000Research: Dataset 1. Raw data of Borrelia spirochetes in human vaginal and seminal secretions, 10.5256/f1000research.5778.d40491 (Middelveen et al., 2014b).

Consent

Written informed consent to publish clinical details and study results was obtained from each participant.

Author contributions

MJM recruited patients, performed the spirochete cultures and wrote the original manuscript. CB, KRF, AT and ES performed the IFA and PCR studies. JB, YW and AF performed the PCR studies. HAS and PJM provided patient samples and edited the manuscript. RBS recruited patients, coordinated all studies, revised the manuscript and edited it for publication. All authors approved the manuscript for publication.

Competing interests

The authors have no competing interests to declare. Preliminary results of the study were presented at the Western Regional Meeting of the American Federation for Medical Research, Carmel, CA, on January 25, 2014, and published in abstract form (J Invest Med 2014;62:280–1).

Grant information

Supported in part by a grant to MJM from the Lindorf Family Foundation, Newark, OH. This work is dedicated to the memory of Dr. Willy Burgdorfer.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Acknowledgements

The authors thank Drs. Stewart Adams, Gordon Atkins, Robert Bransfield, George Chaconas, Douglas Demetrick, Dorte Dopfer, Christopher Hardy, Nick Harris, Doug Kahn, Alan MacDonald, Steve McClain, Kary Mullis, Jyotsna Shah, Leo Shea and Janet Sperling for helpful discussion. We are grateful to Dr. Robert B. Allan, Joel Israel and Anita Vieyra for technical support, and we thank Lorraine Johnson for manuscript review.

Supplementary material

Supplemental figure 1. Molecular hybridization of FlaB probe with Borrelia strains, T. denticola and E.coli.

FlaB hybridization is shown in green, while DAPI counterstain of bacterial targets is shown in blue. Note specific hybridization of FlaB probe with B. burgdorferi sensu stricto and lack of hybridization with other Borrelia strains, T. denticola or E.coli. 400× magnification. See Dataset, data file 4.

Faculty Opinions recommended

References

Aberer E, Duray PH: Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods. J Clin Microbiol. 1991; 29(4): 764–72. PubMed Abstract | Free Full Text
Bach G: Recovery of Lyme spirochetes by PCR in semen samples of previously diagnosed Lyme disease patients. International Scientific Conference on Lyme Disease. 2001. Reference Source
Bankhead T, Chaconas G: The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol Microbiol. 2007; 65(6): 1547–58. PubMed Abstract | Publisher Full Text
Barthold SW, Hodzic E, Imai DM, et al.: Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010; 54(2): 643–51. PubMed Abstract | Publisher Full Text | Free Full Text
Brorson Ø, Brorson S, Scythes J, et al.: Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci U S A. 2009; 106(44): 18656–61. PubMed Abstract | Publisher Full Text | Free Full Text
Burgdorfer W, Barbour AG, Hayes SF, et al.: Lyme disease- a tick-borne spirochetosis? Science. 1982; 216(4552): 1317–9. PubMed Abstract | Publisher Full Text
Burgess EC: Experimental inoculation of mallard ducks (Anas platyrhynchos platyrhynchos) with Borrelia burgdorferi. J Wildl Dis. 1989; 25(1): 99–102. PubMed Abstract | Publisher Full Text
Burgess EC: Experimentally induced infection of cats with Borrelia burgdorferi. Am J Vet Res. 1992; 53(9): 1507–11. PubMed Abstract
Burgess EC, Amundson TE, Davis JP, et al.: Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am J Trop Med Hyg. 1986; 35(2): 355–9. PubMed Abstract
Burgess EC, Patrican LA: Oral infection of Peromyscus maniculatus with Borrelia burgdorferi and subsequent transmission by Ixodes dammini. Am J Trop Med Hyg. 1987; 36(2): 402–7. PubMed Abstract
CDC 2013. Press Release: CDC provides estimate of Americans diagnosed with Lyme disease each year. 2013. Reference Source
CDC: Lyme disease: Laboratory testing. 2014a. Reference Source
CDC: Lyme disease: 2011 case definition. 2014b. Reference Source
Clark KL, Leydet B, Hartman S: Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci. 2013; 10(7): 915–31. PubMed Abstract | Publisher Full Text | Free Full Text
Craig E: Is Lyme disease an STD? Outside Magazine. 2014. Reference Source
Döpfer D, Anklam K, Mikheil D, et al.: Growth curves and morphology of three Treponema subtypes isolated from digital dermatitis in cattle. Vet J. 2012; 193(3): 685–93. PubMed Abstract | Publisher Full Text
Gupta RS, Mahmood S, Adeolu S: A phylogenomic and molecular signature-based approach for characterization of the phylum Spirochaetes and its major clades: proposal for a taxonomic revision of the phylum. Front Microbiol. 2013; 4: 217. PubMed Abstract | Publisher Full Text | Free Full Text
Gustafson JM: The in utero and seminal transmission of Borrelia burgdorferi in Canidae. 1993. PhD thesis, University of Wisconsin, Madison. 2014. Reference Source
Harrison NA, Fitzgerald WR: Leptospirosis--can it be a sexually transmitted disease? Postgrad Med J. 1988; 64(748): 163–4. PubMed Abstract | Publisher Full Text | Free Full Text
Harvey WT, Salvato P: ‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic? Med Hypotheses. 2003; 60(5): 742–59. PubMed Abstract | Publisher Full Text
Ho EL, Lukehart SA: Syphilis: using modern approaches to understand an old disease. J Clin Invest. 2011; 121(12): 4584–92. PubMed Abstract | Publisher Full Text | Free Full Text
Hodzic E, Imai D, Feng S, et al.: Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice. PLoS One. 2014; 9(1): e86907. PubMed Abstract | Publisher Full Text | Free Full Text
Kumi-Diaka J, Harris O: Viability of Borrelia burgdorferi in stored semen. Br Vet J. 1995; 151(2): 221–4. PubMed Abstract | Publisher Full Text
Kurtti TJ, Munderloh UG, Johnson RC, et al.: Colony formation and morphology in Borrelia burgdorferi. J Clin Microbiol. 1987; 25(11): 2054–8. PubMed Abstract | Free Full Text
Lange R, Sayyedi S: Evidence of Lyme borreliosis infection from the viewpoint of laboratory medicine. Int J Med Microbiol. 2002; 291(Suppl 33): 120–4. PubMed Abstract | Publisher Full Text
Maatouk I, Moutran R: History of syphilis: between poetry and medicine. J Sex Med. 2014; 11(1): 307–10. PubMed Abstract | Publisher Full Text
Margos G, Hojgaard A, Lane RS, et al.: Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new Borrelia species, Borrelia kurtenbachii. Ticks Tick Borne Dis. 2010; 1(4): 151–8. PubMed Abstract | Publisher Full Text | Free Full Text
Mayne PJ: Investigations of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue. Clin Cosmet Investig Dermatol. 2012; 5: 69–78. PubMed Abstract | Publisher Full Text | Free Full Text
Mayne PJ: Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort. Int J Gen Med. 2015; 8: 1–12.
Menten-Dedoyart C, Faccinetto C, Golovchenko M, et al.: Neutrophil extracellular traps entrap and kill Borrelia burgdorferi sensu stricto spirochetes and are not affected by Ixodes ricinus tick saliva. J Immunol. 2012; 189(11): 5393–5401. PubMed Abstract | Publisher Full Text
Middelveen MJ, Mayne PJ, Kahn DG, et al.: Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013a; 6: 1–21. PubMed Abstract | Publisher Full Text | Free Full Text
Middelveen MJ, Burugu D, Poruri A, et al.: Association of spirochetal infection with Morgellons disease [v1; ref status: indexed, http://f1000r.es/8g]. F1000Res. 2013b; 2: 25. PubMed Abstract | Publisher Full Text | Free Full Text
Middelveen MJ, McClain SA, Bandoski C, et al.: Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report. Res Open Access. 2014a; 1: 875. Publisher Full Text
Middelveen MJ, Burke J, Sapi E, et al.: Raw data of Borrelia spirochetes in human vaginal and seminal secretions. F1000Research. 2014b. Data Source
Moody KD, Barthold SW: Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Amer J Trop Med Hyg. 1991; 44(2): 135–9. PubMed Abstract
Mursic VP, Wanner G, Reinhardt S, et al.: Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection. 1996; 24(3): 218–26. PubMed Abstract | Publisher Full Text
Nolte O: Nucleic Acid Amplification Based Diagnostic of Lyme (Neuro-)borreliosis - Lost in the Jungle of Methods, Targets, and Assays? Open Neurol J. 2012: 6(Suppl 1–M7): 129–139. PubMed Abstract | Publisher Full Text | Free Full Text
O’Rourke M, Traweger A, Lusa L, et al.: Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One. 2013; 8(5): e63968. PubMed Abstract | Publisher Full Text | Free Full Text
Pathak S, Lau YF, Drwinga HL: Observations on the synaptonemal complex in Armenian hamster spermatocytes by light microscopy. Chromosoma. 1979; 73(1): 53–60. PubMed Abstract | Publisher Full Text
Sapi E, Pabbati N, Datar A, et al.: Improved culture conditions for the growth and detection of Borrelia from human serum. Int J Med Sci. 2013; 10(4): 362–76. PubMed Abstract | Publisher Full Text | Free Full Text
Schmidt BL: PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev. 1997; 10(1): 185–201. PubMed Abstract | Free Full Text
Schmid M, Müller H, Stasch S, et al.: Silver staining of nucleolus organizer regions during human spermatogenesis. Hum Genet. 1983; 64(4): 363–70. PubMed Abstract | Publisher Full Text
Shaw GM, Hunter E: HIV transmission. Cold Spring Harb Perspect Med. 2012; 2(11): a006965. PubMed Abstract | Publisher Full Text | Free Full Text
Stricker RB, Johnson L: Lyme disease: Call for a “Manhattan Project” to combat the epidemic. PLoS Pathog. 2014; 10(1): e1003796. PubMed Abstract | Publisher Full Text | Free Full Text
Stricker RB, Moore DH, Winger EE: Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact. J Investig Med. 2004; 52: S151.
Woodrum JE, Oliver JH Jr: Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol. 1999; 85(3): 426–30. PubMed Abstract | Publisher Full Text
Wright SD, Nielsen SW: Experimental infection of the white-footed mouse with Borrelia burgdorferi. Am J Vet Res. 1990; 51(12): 1980–7. PubMed Abstract
Yang J, Liu Z, Guan G, et al.: Evaluation of molecular methods for detection of Borrelia burgdorferi senso lato in ticks. Diagn Microbiol Infect Dis. 2012; 73(1): 80–3. PubMed Abstract | Publisher Full Text

Comments on this article Comments (5)

Version 3

VERSION 3 PUBLISHED 27 Apr 2015

Revised

Comment

Version 1

VERSION 1 PUBLISHED 18 Dec 2014

Discussion is closed on this version, please comment on the latest version above.

Reader Comment 22 Jan 2015

Phillip Baker, American Lyme Disease Foundation, USA

22 Jan 2015

Reader Comment

Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps ... Continue reading Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps Dr. Stricker would like to offer an explanation as to how long -- if at all-- B. burgdorferi is likely to survive in such a "hostile" environment.
Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps Dr. Stricker would like to offer an explanation as to how long -- if at all-- B. burgdorferi is likely to survive in such a "hostile" environment.
Competing Interests: None Close
Report a concern
Reader Comment 20 Jan 2015

Sin Hang Lee, Milford Molecular Diagnostics, USA

20 Jan 2015

Reader Comment

Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates¹ were published before ... Continue reading Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates[ref-1] were published before the discovery of antibodies. In fact, attempts to rely on the Widal test (an antibody test) to diagnose typhoid fever were rejected more than 100 years ago[ref-2]. A CDC document clearly states that serology tests are not reliable for the diagnosis of typhoid fever[ref-3]. If the Koch’s postulates are to be applied in the diagnosis of Lyme disease, alternative methods, e.g. DNA sequencing-based tests[ref-4], to detect causative agents must be used.

[References]
[[1|title=Untersuchungen Über die Aetiologie der Wundinfectionskrankheiten|authors=Koch/R|vol= Leipzig: F.C.W. Vogel|year=1878]]
[[2|title=Zur Ätiologie und Pathogenese des Abdominaltyphus|authors=Jürgens/GJ|vol=Ztschr. f. klin. Med., Berl.|year=1904]]
[[3|title=Chapter 3 Infectious Diseases Related To Travel: Typhoid & Paratyphoid Fever In CDC Health Information for International Travel|authors=Newton/AE;Mintz/E |source=CDC|year=August 01, 2013|url=http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/typhoid-and-paratyphoid-fever]]
[[4|title=DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections|authors=Lee/SH;Vigliotti/JS;Vigliotti/VS;Jones/W;Moorcroft/TA;Lantsman/K|source=Int J Mol Sci|vol=15|issue=7|year=2014|fpage=11364|lpage=11386|type=journal|doi=10.3390/ijms150711364|pmid=24968274]]
Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates¹ were published before the discovery of antibodies. In fact, attempts to rely on the Widal test (an antibody test) to diagnose typhoid fever were rejected more than 100 years ago². A CDC document clearly states that serology tests are not reliable for the diagnosis of typhoid fever³. If the Koch’s postulates are to be applied in the diagnosis of Lyme disease, alternative methods, e.g. DNA sequencing-based tests⁴, to detect causative agents must be used.

References
1. Koch R: Untersuchungen Über die Aetiologie der Wundinfectionskrankheiten. 1878; Leipzig: F.C.W. Vogel.
2. Jürgens GJ: Zur Ätiologie und Pathogenese des Abdominaltyphus. 1904; Ztschr. f. klin. Med., Berl..
3. Newton AE, Mintz E: Chapter 3 Infectious Diseases Related To Travel: Typhoid & Paratyphoid Fever In CDC Health Information for International Travel. CDC. August 01, 2013. Reference Source
4. Lee SH, Vigliotti JS, Vigliotti VS, Jones W, et al.: DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections. Int J Mol Sci. 2014; 15 (7): 11364-11386 PubMed Abstract | Publisher Full Text
Competing Interests: Competing Interests: Dr. Sin Hang Lee is the director of Milford Molecular Diagnostics, a CLIA-certified laboratory offering DNA sequencing-based tests for Lyme and related borrelioses Close
Report a concern
Reader Comment 12 Jan 2015

Phillip Baker, American Lyme Disease Foundation, USA

12 Jan 2015

Reader Comment

Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and ... Continue reading Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and vaginal secretions, if that finding indeed can be confirmed independently by other investigators, does not prove that they cause disease, especially in view of the fact that most of the patients examined were not seropositive by standard CDC test criteria. Perhaps Dr. Stricker ought to review Koch's postulates for guidance in that regard. In the absence of such proof, it is irresponsible and not in the best interest of the public health for Dr. Stricker to alarm the public by touting the results of preliminary and unconfirmed findings in the press.

Most recent data from the CDC still continue to show that, unlike the reported incidence of sexually transmitted diseases, reported cases of Lyme disease are concentrated in the same 13 States as in previous years. Obviously, the epidemiology is the same whether the reported number of cases is 30K or 300K per year.
Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and vaginal secretions, if that finding indeed can be confirmed independently by other investigators, does not prove that they cause disease, especially in view of the fact that most of the patients examined were not seropositive by standard CDC test criteria. Perhaps Dr. Stricker ought to review Koch's postulates for guidance in that regard. In the absence of such proof, it is irresponsible and not in the best interest of the public health for Dr. Stricker to alarm the public by touting the results of preliminary and unconfirmed findings in the press.

Most recent data from the CDC still continue to show that, unlike the reported incidence of sexually transmitted diseases, reported cases of Lyme disease are concentrated in the same 13 States as in previous years. Obviously, the epidemiology is the same whether the reported number of cases is 30K or 300K per year.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Author Response 07 Jan 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

07 Jan 2015

Author Response

Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, ... Continue reading Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, immunochemistry, molecular hybridization and polymerase chain reaction (PCR) techniques to demonstrate the presence of these live spirochetes in cultures of genital secretions, and as stated in the study our results suggest that Lyme disease could be sexually transmitted. All of the concerns in Baker’s commentary were previously aired on the Internet, and these concerns were addressed in our report. His objection has little merit for the reasons described below.

Baker represents a group of researchers who cling to the concept that Lyme disease is a trivial illness that is "hard to catch and easy to cure", and that chronic Lyme disease due to persistent infection with the Lyme spirochete, Borrelia burgdorferi, is rare or non-existent[ref-1]^,[ref-2]. As discussed elsewhere, this "Lyme denialist" philosophy and disregard for opposing viewpoints has been a major factor in the epidemic spread of Lyme disease, which accounts for more than 300,000 new cases per year in the USA according to the latest Centers for Disease Control and Prevention (CDC) estimates[ref-2]. As stated in our article, this alarming epidemic is twice as common as breast cancer and six times more common than HIV/AIDS, and its prevalence is hard to explain by tickbite transmission alone. Thus from an epidemiological perspective, sexual transmission of the live Borrelia spirochetes found in genital secretions is a plausible mechanism for the spread of Lyme disease.

Baker's commentary on our article uses selective information that supports his point of view while ignoring contradictory evidence. He starts with two animal models that appear to refute contact or sexual transmission of Lyme disease, and he concludes with selective epidemiological evidence from the CDC that obliquely supports his view. Sandwiched in between is a flawed discussion of maternal-fetal transmission of Lyme disease that has no bearing on sexual transmission of the spirochetal infection. Although we have addressed the animal model and epidemiological issues in our article, we will address these issues in greater detail below. We will leave it to readers to find the flaws in Baker's denial of maternal-fetal transmission of Lyme disease, since this form of transmission has been documented in canine, bovine, murine and human reports from the peer-reviewed medical literature[ref-3]^-[ref-8].

Baker cites two animal studies as proof that Lyme disease cannot be sexually transmitted[ref-9]^,[ref-10]. The study by Moody and Barthold was performed using Lewis rats, while the study by Woodrum and Oliver was performed using Syrian hamsters. In limiting his analysis to these two studies, Baker ignores the compelling observations in mice, birds, cats and dogs that support contact or sexual transmission of Lyme disease without a tick vector, as outlined in our report[ref-4]^,[ref-11]^-[ref-13]. The Lewis rat and Syrian hamster studies had significant flaws. First, these rodents are highly inbred with all Lewis rats descended from a single breeding colony, and all Syrian hamsters descended from a single female breeder[ref-14]^,[ref-15]. The effect of inbreeding on contact transmission of Borrelia is unknown. Second, these rodents are poor models for human Lyme disease. The Lewis rat develops a transient arthritis that fades without treatment following intraperitoneal injection of Borrelia, while the Syrian hamster may be colonized by Borrelia for long periods without showing any signs of disease[ref-16]^,[ref-17]. Since the disease pattern in these animals differs significantly from the human pattern, it is not surprising that transmission of Borrelia would differ as well. In fact, the immunocompetent Syrian hamster has been abandoned as a model for human Lyme disease because of these differences. Third and perhaps most important, both studies used limited culture and immunological methods to determine sexual transmission of Borrelia, and more sensitive detection of spirochetes by molecular techniques might have yielded positive results, as shown in other rodent experiments using PCR[ref-4]. Thus the selective animal models cited by Baker fail to refute the possibility of sexual transmission of Lyme disease in humans.

Baker attempts to use CDC surveillance statistics to further disprove sexual transmission of Lyme disease. He points to the fact that 95% of reported CDC surveillance cases occur in 12 states in the USA, and that these reported cases are seasonal and have a male and child predominance. As pointed out in our article, however, CDC surveillance cases account for less than 10% of total Lyme cases (about 30,000 cases out of more than 300,000 annual cases in the USA). Thus the epidemiology of the vast majority of Lyme cases is not covered by CDC surveillance reporting and may differ significantly from the epidemiology reported by the CDC. To support this view, as noted in our study, a recent report from Australia found that the prevalence of Lyme disease cases aligned with the sexually active population on that continent[ref-18]. Baker also questions whether our Lyme disease testing was accurate since it differs from the serological parameters used for CDC surveillance criteria. However the CDC surveillance criteria rely on testing that misses more than half of Lyme disease cases[ref-19], and these criteria are not recommended for diagnosis of Lyme disease[ref-20]. The reason why Baker thinks that insensitive and incomplete epidemiology statistics trump microscopy, immunochemistry, molecular hybridization and PCR testing that demonstrates live, culturable Borrelia spirochetes in genital secretions from our Lyme disease patients is unclear.

Baker bemoans the fact that because of the inconvenient evidence presented in our study, Lyme disease patients may suddenly be concerned about sexual transmission of their disease. Because Baker does not represent or treat patients, he may be unaware that this question is being asked by patients in clinicians’ offices every day as spouses and sexual partners become symptomatic. Should Lyme disease patients be concerned about sexual transmission? Absolutely. We currently treat Lyme disease with 60-year-old antibiotics that are marginally effective against a chronic infectious disease[ref-1]^,[ref-21]. Baker and his research associates should focus on the risk of sexual transmission of Borrelia and strive to develop new treatments for this alarming epidemic infection along the lines of the global "Manhattan Project" that has successfully dealt with the HIV/AIDS epidemic[ref-2]^,[ref-19]. Our suffering Lyme disease patients deserve nothing less.

[References]
[[1|title=Lyme disease: The next decade|authors=Stricker/RB;Johnson/L|source= Infect Drug Resist|vol=4|year=2011|fpage=1|lpage=9|type=journal|pmid=21694904|pmcid= PMC3108755]]
[[2|title=Lyme disease: Call for a “Manhattan Project” to combat the epidemic|authors=Stricker/RB;Johnson/L|source=PLoS Pathog|vol=10|issue=1|year=2014|fpage=e1003796|type=Journal|doi=10.1371/journal.ppat.1003796|pmid=24391491|pmcid=PMC3879353]]
[[3|title=Intrauterine transmission of Borrelia burgdorferi in dogs|authors=Gustafson/JM;Burgess/EC;Wachal/MD;Steinberg/H|source=Am J Vet Res|vol=54|issue=6|year=1993|fpage=882|lpage=890|type=journal|pmid= 8323057]]
[[4|title=Borrelia burgdorferi infection in dairy cows, rodents, and birds from four Wisconsin dairy farms|authors=Burgess/EC;Wachal/MD;Cleven/TD|source=Vet Microbiol|vol=35|issue=1-2|year=1993|fpage=61|lpage=77|type=journal|pmid=8362496]]
[[5|title=Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi|authors=Schlesinger/PA;Duray/PH;Burke/BA;Steere/AC;Stillman/MT|source= Ann Intern Med|vol=103|issue=1|year=1985|fpage=67|lpage=68|type=journal|pmid=4003991]]
[[6|title=Lyme Borrelia positive serology associated with spontaneous abortion in an endemic Italian area|authors=Carlomagno/G;Luksa/V;Candussi/G;Rizzi/GM;Trevisan/G|source=Acta Eur Fertil|vol=19|issue=5|year=1988|fpage=279|lpage=281|type=Journal|pmid=3252658]]
[[7|title=Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy|authors=Weber/K;Bratzke/HJ;Neubert/U;Wilske/B;Duray/PH|source=Pediatr Infect Dis J|vol=7|issue=4|year=1988|fpage=286|lpage=289|type=journal|pmid=3130607]]
[[8|title=Gestational Lyme borreliosis: implications for the fetus|authors=MacDonald/AB|source=Rheum Dis Clin North Am|vol=15|issue=4|year=1989|fpage=657|lpage=677|type=journal|pmid=2685924]]
[[9|title=Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation|authors=Moody/KD;Barthold/SW|source= Am J Trop Med Hyg|vol=44|issue=2|year=1991|fpage=135|lpage=139|type=journal|pmid=2012256]]
[[10|title=Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters|authors=Woodrum/JE;Oliver/JH|source=J Parasitol|vol=85|issue=3|year=1999|fpage=426|lpage=430|type=journal|pmid=10386432]]
[[11|title=Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: Evidence of contact transmission|authors=Burgess/EC;Amundson/TE;Davis/JP;Kaslow/RA;Edelman/R|source=Am J Trop Med Hyg|vol=35|issue=2|year=1986|fpage=355|lpage=359|type=journal|pmid=3513648]]
[[12|title=Experimental infection of the white-footed mouse with Borrelia burgdorferi|authors=Wright/SD;Nielsen/SW|source=Am J Vet Res|vol=51|issue=12|year=1990|fpage=1980|lpage=1987|type=journal|pmid=2085225]]
[[13|title=The in utero and seminal transmission of Borrelia burgdorferi in Canidae (PhD thesis, University of Wisconsin, Madison; Accessed: December 30, 2014)|authors=Gustafson/JM|year=1993|url=http://search.library.wisc.edu/catalog/ocm29551629]]
[[14|title=Lewis rat (Accessed: December 30, 2014)|source=Wikipedia|url=http://en.wikipedia.org/wiki/Laboratory_rat]]
[[15|title=Golden hamster (Accessed: December 30, 2014)|source=Wikipedia|url=http://en.wikipedia.org/wiki/Golden_hamster]]
[[16|title=Experimental chronic Lyme borreliosis in Lewis rats|authors=Moody/KD;Barthold/SW;Terwilliger/GA;Beck/DS;Hansen/GM;Jacoby/RO|source=Am J Trop Med Hyg|vol=42|issue=2|year=1990|fpage=165|lpage=174|type=journal|pmid=2138431]]
[[17|title=Experimental infection of the hamster with Borrelia burgdorferi|authors=Johnson/RC;Codner/C;Russell/M;Duray/PH|source=Ann N Y Acad Sci|vol=539|year=1988|fpage=258|lpage=263|type=journal|doi=10.1111/j.1749-6632.1988.tb31859.x]]
[[18|title=Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort|authors=Mayne/PJ|source=Int J Gen Med|vol=8|year=2015|fpage=15|lpage=26|type=journal|doi=10.2147/IJGM.S75825|url= http://www.dovepress.com/clinical-determinants-of-lyme-borreliosis-babesiosis-bartonellosis-ana-peer-reviewed-article-IJGM#]]
[[19|title=Lyme disease diagnosis and treatment: lessons from the AIDS epidemic|authors=Stricker/RB;Johnson/L|source=Minerva Med|vol=101|issue=6|year=2010|fpage=419|lpage=425|type=journal|pmid=21196901]]
[[20|title= Lyme disease: 2011 case definition (Accessed: December 30, 2014)|source=CDC|url=http://wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrID=752andDatePub=1/1/2011%2012:00:00%20AM.]]
[[21|title=Relevance of chronic Lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review|authors=Borgermans/L;Goderis/G;Vandevoorde/J;Devroey/D|source=Int J Family Med|vol=2014|year=2014|type=journal|doi=10.1155/2014/138016|url=http://www.hindawi.com/journals/ijfm/2014/138016/]]
Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, immunochemistry, molecular hybridization and polymerase chain reaction (PCR) techniques to demonstrate the presence of these live spirochetes in cultures of genital secretions, and as stated in the study our results suggest that Lyme disease could be sexually transmitted. All of the concerns in Baker’s commentary were previously aired on the Internet, and these concerns were addressed in our report. His objection has little merit for the reasons described below.

Baker represents a group of researchers who cling to the concept that Lyme disease is a trivial illness that is "hard to catch and easy to cure", and that chronic Lyme disease due to persistent infection with the Lyme spirochete, Borrelia burgdorferi, is rare or non-existent¹^,². As discussed elsewhere, this "Lyme denialist" philosophy and disregard for opposing viewpoints has been a major factor in the epidemic spread of Lyme disease, which accounts for more than 300,000 new cases per year in the USA according to the latest Centers for Disease Control and Prevention (CDC) estimates². As stated in our article, this alarming epidemic is twice as common as breast cancer and six times more common than HIV/AIDS, and its prevalence is hard to explain by tickbite transmission alone. Thus from an epidemiological perspective, sexual transmission of the live Borrelia spirochetes found in genital secretions is a plausible mechanism for the spread of Lyme disease.

Baker's commentary on our article uses selective information that supports his point of view while ignoring contradictory evidence. He starts with two animal models that appear to refute contact or sexual transmission of Lyme disease, and he concludes with selective epidemiological evidence from the CDC that obliquely supports his view. Sandwiched in between is a flawed discussion of maternal-fetal transmission of Lyme disease that has no bearing on sexual transmission of the spirochetal infection. Although we have addressed the animal model and epidemiological issues in our article, we will address these issues in greater detail below. We will leave it to readers to find the flaws in Baker's denial of maternal-fetal transmission of Lyme disease, since this form of transmission has been documented in canine, bovine, murine and human reports from the peer-reviewed medical literature³^-⁸.

Baker cites two animal studies as proof that Lyme disease cannot be sexually transmitted⁹^,¹⁰. The study by Moody and Barthold was performed using Lewis rats, while the study by Woodrum and Oliver was performed using Syrian hamsters. In limiting his analysis to these two studies, Baker ignores the compelling observations in mice, birds, cats and dogs that support contact or sexual transmission of Lyme disease without a tick vector, as outlined in our report⁴^,¹¹^-¹³. The Lewis rat and Syrian hamster studies had significant flaws. First, these rodents are highly inbred with all Lewis rats descended from a single breeding colony, and all Syrian hamsters descended from a single female breeder¹⁴^,¹⁵. The effect of inbreeding on contact transmission of Borrelia is unknown. Second, these rodents are poor models for human Lyme disease. The Lewis rat develops a transient arthritis that fades without treatment following intraperitoneal injection of Borrelia, while the Syrian hamster may be colonized by Borrelia for long periods without showing any signs of disease¹⁶^,¹⁷. Since the disease pattern in these animals differs significantly from the human pattern, it is not surprising that transmission of Borrelia would differ as well. In fact, the immunocompetent Syrian hamster has been abandoned as a model for human Lyme disease because of these differences. Third and perhaps most important, both studies used limited culture and immunological methods to determine sexual transmission of Borrelia, and more sensitive detection of spirochetes by molecular techniques might have yielded positive results, as shown in other rodent experiments using PCR⁴. Thus the selective animal models cited by Baker fail to refute the possibility of sexual transmission of Lyme disease in humans.

Baker attempts to use CDC surveillance statistics to further disprove sexual transmission of Lyme disease. He points to the fact that 95% of reported CDC surveillance cases occur in 12 states in the USA, and that these reported cases are seasonal and have a male and child predominance. As pointed out in our article, however, CDC surveillance cases account for less than 10% of total Lyme cases (about 30,000 cases out of more than 300,000 annual cases in the USA). Thus the epidemiology of the vast majority of Lyme cases is not covered by CDC surveillance reporting and may differ significantly from the epidemiology reported by the CDC. To support this view, as noted in our study, a recent report from Australia found that the prevalence of Lyme disease cases aligned with the sexually active population on that continent¹⁸. Baker also questions whether our Lyme disease testing was accurate since it differs from the serological parameters used for CDC surveillance criteria. However the CDC surveillance criteria rely on testing that misses more than half of Lyme disease cases¹⁹, and these criteria are not recommended for diagnosis of Lyme disease²⁰. The reason why Baker thinks that insensitive and incomplete epidemiology statistics trump microscopy, immunochemistry, molecular hybridization and PCR testing that demonstrates live, culturable Borrelia spirochetes in genital secretions from our Lyme disease patients is unclear.

Baker bemoans the fact that because of the inconvenient evidence presented in our study, Lyme disease patients may suddenly be concerned about sexual transmission of their disease. Because Baker does not represent or treat patients, he may be unaware that this question is being asked by patients in clinicians’ offices every day as spouses and sexual partners become symptomatic. Should Lyme disease patients be concerned about sexual transmission? Absolutely. We currently treat Lyme disease with 60-year-old antibiotics that are marginally effective against a chronic infectious disease¹^,²¹. Baker and his research associates should focus on the risk of sexual transmission of Borrelia and strive to develop new treatments for this alarming epidemic infection along the lines of the global "Manhattan Project" that has successfully dealt with the HIV/AIDS epidemic²^,¹⁹. Our suffering Lyme disease patients deserve nothing less.

References
1. Stricker RB, Johnson L: Lyme disease: The next decade. Infect Drug Resist. 2011; 4: 1-9 PubMed Abstract | Free Full Text
2. Stricker RB, Johnson L: Lyme disease: Call for a “Manhattan Project” to combat the epidemic. PLoS Pathog. 2014; 10 (1): e1003796 PubMed Abstract | Free Full Text | Publisher Full Text
3. Gustafson JM, Burgess EC, Wachal MD, Steinberg H: Intrauterine transmission of Borrelia burgdorferi in dogs. Am J Vet Res. 1993; 54 (6): 882-890 PubMed Abstract
4. Burgess EC, Wachal MD, Cleven TD: Borrelia burgdorferi infection in dairy cows, rodents, and birds from four Wisconsin dairy farms. Vet Microbiol. 1993; 35 (1-2): 61-77 PubMed Abstract
5. Schlesinger PA, Duray PH, Burke BA, Steere AC, et al.: Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med. 1985; 103 (1): 67-68 PubMed Abstract
6. Carlomagno G, Luksa V, Candussi G, Rizzi GM, et al.: Lyme Borrelia positive serology associated with spontaneous abortion in an endemic Italian area. Acta Eur Fertil. 1988; 19 (5): 279-281 PubMed Abstract
7. Weber K, Bratzke HJ, Neubert U, Wilske B, et al.: Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J. 1988; 7 (4): 286-289 PubMed Abstract
8. MacDonald AB: Gestational Lyme borreliosis: implications for the fetus. Rheum Dis Clin North Am. 1989; 15 (4): 657-677 PubMed Abstract
9. Moody KD, Barthold SW: Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Am J Trop Med Hyg. 1991; 44 (2): 135-139 PubMed Abstract
10. Woodrum JE, Oliver JH: Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol. 1999; 85 (3): 426-430 PubMed Abstract
11. Burgess EC, Amundson TE, Davis JP, Kaslow RA, et al.: Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: Evidence of contact transmission. Am J Trop Med Hyg. 1986; 35 (2): 355-359 PubMed Abstract
12. Wright SD, Nielsen SW: Experimental infection of the white-footed mouse with Borrelia burgdorferi. Am J Vet Res. 1990; 51 (12): 1980-1987 PubMed Abstract
13. Gustafson JM: The in utero and seminal transmission of Borrelia burgdorferi in Canidae (PhD thesis, University of Wisconsin, Madison; Accessed: December 30, 2014). 1993. Reference Source
14. Lewis rat (Accessed: December 30, 2014). Wikipedia. Reference Source
15. Golden hamster (Accessed: December 30, 2014). Wikipedia. Reference Source
16. Moody KD, Barthold SW, Terwilliger GA, Beck DS, et al.: Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg. 1990; 42 (2): 165-174 PubMed Abstract
17. Johnson RC, Codner C, Russell M, Duray PH: Experimental infection of the hamster with Borrelia burgdorferi. Ann N Y Acad Sci. 1988; 539: 258-263 Publisher Full Text
18. Mayne PJ: Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort. Int J Gen Med. 2015; 8: 15-26 Publisher Full Text | Reference Source
19. Stricker RB, Johnson L: Lyme disease diagnosis and treatment: lessons from the AIDS epidemic. Minerva Med. 2010; 101 (6): 419-425 PubMed Abstract
20. Lyme disease: 2011 case definition (Accessed: December 30, 2014). CDC. Reference Source
21. Borgermans L, Goderis G, Vandevoorde J, Devroey D: Relevance of chronic Lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review. Int J Family Med. 2014; 2014. Publisher Full Text | Reference Source
Competing Interests: None Close
Report a concern
Reader Comment 29 Dec 2014

Phillip Baker, American Lyme Disease Foundation, USA

29 Dec 2014

Reader Comment
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold ... Continue reading
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold², as well as Woodrum and Oliver³, internationally known experts on Lyme disease. These investigators used well-characterized animal models of borreliosis in which infection is much more disseminated and profound than it ever is in humans. It should be noted that, in the United States, Lyme borreliosis has historically been defined as a tick borne infection caused by Borrelia burgdorferi sensu lato⁴.

To determine if borreliosis can be transmitted by direct contact, Moody and Barthold ² housed three-day-old - or three-week-old- Lewis rats, deliberately infected with B. burgdorferi, with normal, uninfected rats for 30 days. As expected, all deliberately infected rats continued to be actively infected, 30 days later; however, none of the uninfected rats acquired infection after 30 days of intimate direct contact with their
infected house mates.

In other experiments, Moody and Barthold ²were unable to demonstrate venereal transmission of borreliosis from seven infected females-or six infected males - to uninfected rats of the opposite sex.

In the work of Woodrum and Oliver ³, six female Syrian hamsters infected with B.burgdorferi were mated with six uninfected males; conversely, three infected males were mated with six uninfected females. None of the uninfected hamsters became infected after mating with an infected partner of the opposite sex, indicating that borreliosis is not sexually transmitted. These investigators also failed to demonstrate contact transmission of B. burgdorferi between infected female -or male-hamsters and uninfected hamsters of the opposite sex. Also, it was not possible to transmit borreliosis to uninfected hamsters with urine or feces from infected hamsters.

Sadly, preliminary oral reports of the observations of Middelveen et al.¹ have already generated an inordinate amount of fear and anxiety within the lay community due to sensationalized reports of their unconfirmed findings by an uncritical - and often naïve - press. This has already caused much harm. To date, I have received numerous inquiries from distraught individuals, wondering if they now should even consider marrying their spouse-to-be for fear of contracting Lyme disease that some mistakenly believe to be incurable. Some fear the possibility of giving birth to an infected or congenitally deformed child, because their spouse or spouse-to-be had been diagnosed and treated for Lyme disease in the past.

To examine the issue of in utero transmission of infection, Moody and Barthold ² inoculated pregnant female Lewis rats with viable B. burgdorferi, at four days of gestation. All of the inoculated pregnant females became seropositive as expected, and B. burgdorferi could be cultured from their spleens at 20 days of gestation; however, their placentas and fetuses were culture negative, indicting the lack of in utero transmission.

Moody and Barthold ² used two different experimental protocols to determine if transplacental transmission of B. burgdorferi occurs. One protocol involved six non-pregnant infected females that were subsequently mated and became pregnant. Three of the females were allowed to carry to full term, whereas the remaining three were sacrificed just prior to parturition. All offspring and offspring-to-be were found to be culture negative for B. burgdorferi, as well as seronegative for antibody specific for B. burgdorferi, indicating that transplacental transmission of infection does not occur.

In the second protocol, six females were infected via tick bite after becoming pregnant, and were allowed to carry their fetuses to birth; all were negative for infection. The results of these studies likewise failed to provide evidence for the transplacental transmission of naturally acquired borreliosis.

Other investigators examined the possibility of congenital birth defects in humans with Lyme disease by doing a rather large comparative study involving 5,000 infants, half from an area in which Lyme disease was endemic and half as controls from an area without Lyme disease ⁵. They found no significant differences in the overall incidence of congenital malformations between the two groups.

In another study, involving 1,500 subjects including controls, no increased risk of giving birth to a child with a congenital heart defect was noted in women who had either been bitten by a tick or had been treated for Lyme disease during or before pregnancy ⁶.

Finally, an extensive analysis of the world literature revealed “that an adverse outcome due to maternal infection with B. burgdorferi at any point during pregnancy in humans is at most extremely rare” ⁷.

In view of the above considerations, the work by Middelveen et al. ¹ is not credible and must be view with much skepticism. There is no evidence to indicate that vaginal and seminal secretions provide a suitable environment for the growth of Borrelia ⁸ and that the mere presence of Borrelia in vaginal and seminal secretions – if such an observation is indeed valid and can be confirmed independently – results in disease. In the absence of such proof, no conclusions can be drawn as to the sexual transmission of Lyme disease by of B. burgdorferi.

Addendum added in proof:

It should be noted that the basic epidemiology of vector-borne Lyme disease is strikingly different from that for sexually transmitted diseases (STDs). For example, annual data provided by the CDC indicate that about 95% of all reported cases of Lyme disease occur in 12 States, and the incidence of Lyme disease is seasonal and peaks with increased tick activity. Also, in the case of STDs, there are more husband-wife paired cases rather than the preponderance of cases of males and children with Lyme disease. Most important, Middelveen et al. state that “… the majority of our study subjects did not meet the positive standard as defined by the CDC surveillance criteria.” One must therefore wonder if their study subjects ever had Lyme disease in the first place.

References
Middleveen, MJ, Burke, J., Sapi, E., et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. [v1; ref status: awaiting peer review, http://f1000r.es/4rm] published 19 December 2014, F1000Research 2014, 3:309 (doi:10.12688/f1000 research.57778.1).

Moody, KD, and Barthold, SW. Relative infectivity of Borrelia burgdorferi in Lewis rats by varius routes of inoculation. Amer. J. Trop. Med. Hyg. 1991; 44: 135-139.

Woodrum, JE, and Oliver, JH Jr. Investigation of venereal, transplacental, and contact transmission of the Lyme disease sprirochete, Borrelia burgdorferi, in Syrian hamsters. J. Parasitol. 1999: 85, 426-430.

Wormser, GP, and O’Connell, S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert. Rev. Anti. Infect. Ther. 2011; 9: 245-260.

Williams, CL, Strobino, B, Weinstein, A. et al. Maternal Lyme disease; congenital malformations and a cord blood serosurvey in endemic and control areas. Paediatr. Perinat. Epidemiol. 1995; 180: 711-716.

Strobino, B, Abid, S, and Gewitz, M. Maternal Lyme disease and congential heart disease: a case control study in an endemic area. Am. J. Obstet. Gynecol. 199; 180: 711-716.

Elliot, DJ, Eppes, SC, and Klein, JD. Teratogen Update: Lyme disease. Teratology 2001; 64: 276-286.

http://www.cdc.gov/lyme/faq/#sexually
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold², as well as Woodrum and Oliver³, internationally known experts on Lyme disease. These investigators used well-characterized animal models of borreliosis in which infection is much more disseminated and profound than it ever is in humans. It should be noted that, in the United States, Lyme borreliosis has historically been defined as a tick borne infection caused by Borrelia burgdorferi sensu lato⁴.

To determine if borreliosis can be transmitted by direct contact, Moody and Barthold ² housed three-day-old - or three-week-old- Lewis rats, deliberately infected with B. burgdorferi, with normal, uninfected rats for 30 days. As expected, all deliberately infected rats continued to be actively infected, 30 days later; however, none of the uninfected rats acquired infection after 30 days of intimate direct contact with their
infected house mates.

In other experiments, Moody and Barthold ²were unable to demonstrate venereal transmission of borreliosis from seven infected females-or six infected males - to uninfected rats of the opposite sex.

In the work of Woodrum and Oliver ³, six female Syrian hamsters infected with B.burgdorferi were mated with six uninfected males; conversely, three infected males were mated with six uninfected females. None of the uninfected hamsters became infected after mating with an infected partner of the opposite sex, indicating that borreliosis is not sexually transmitted. These investigators also failed to demonstrate contact transmission of B. burgdorferi between infected female -or male-hamsters and uninfected hamsters of the opposite sex. Also, it was not possible to transmit borreliosis to uninfected hamsters with urine or feces from infected hamsters.

Sadly, preliminary oral reports of the observations of Middelveen et al.¹ have already generated an inordinate amount of fear and anxiety within the lay community due to sensationalized reports of their unconfirmed findings by an uncritical - and often naïve - press. This has already caused much harm. To date, I have received numerous inquiries from distraught individuals, wondering if they now should even consider marrying their spouse-to-be for fear of contracting Lyme disease that some mistakenly believe to be incurable. Some fear the possibility of giving birth to an infected or congenitally deformed child, because their spouse or spouse-to-be had been diagnosed and treated for Lyme disease in the past.

To examine the issue of in utero transmission of infection, Moody and Barthold ² inoculated pregnant female Lewis rats with viable B. burgdorferi, at four days of gestation. All of the inoculated pregnant females became seropositive as expected, and B. burgdorferi could be cultured from their spleens at 20 days of gestation; however, their placentas and fetuses were culture negative, indicting the lack of in utero transmission.

Moody and Barthold ² used two different experimental protocols to determine if transplacental transmission of B. burgdorferi occurs. One protocol involved six non-pregnant infected females that were subsequently mated and became pregnant. Three of the females were allowed to carry to full term, whereas the remaining three were sacrificed just prior to parturition. All offspring and offspring-to-be were found to be culture negative for B. burgdorferi, as well as seronegative for antibody specific for B. burgdorferi, indicating that transplacental transmission of infection does not occur.

In the second protocol, six females were infected via tick bite after becoming pregnant, and were allowed to carry their fetuses to birth; all were negative for infection. The results of these studies likewise failed to provide evidence for the transplacental transmission of naturally acquired borreliosis.

Other investigators examined the possibility of congenital birth defects in humans with Lyme disease by doing a rather large comparative study involving 5,000 infants, half from an area in which Lyme disease was endemic and half as controls from an area without Lyme disease ⁵. They found no significant differences in the overall incidence of congenital malformations between the two groups.

In another study, involving 1,500 subjects including controls, no increased risk of giving birth to a child with a congenital heart defect was noted in women who had either been bitten by a tick or had been treated for Lyme disease during or before pregnancy ⁶.

Finally, an extensive analysis of the world literature revealed “that an adverse outcome due to maternal infection with B. burgdorferi at any point during pregnancy in humans is at most extremely rare” ⁷.

In view of the above considerations, the work by Middelveen et al. ¹ is not credible and must be view with much skepticism. There is no evidence to indicate that vaginal and seminal secretions provide a suitable environment for the growth of Borrelia ⁸ and that the mere presence of Borrelia in vaginal and seminal secretions – if such an observation is indeed valid and can be confirmed independently – results in disease. In the absence of such proof, no conclusions can be drawn as to the sexual transmission of Lyme disease by of B. burgdorferi.

Addendum added in proof:

It should be noted that the basic epidemiology of vector-borne Lyme disease is strikingly different from that for sexually transmitted diseases (STDs). For example, annual data provided by the CDC indicate that about 95% of all reported cases of Lyme disease occur in 12 States, and the incidence of Lyme disease is seasonal and peaks with increased tick activity. Also, in the case of STDs, there are more husband-wife paired cases rather than the preponderance of cases of males and children with Lyme disease. Most important, Middelveen et al. state that “… the majority of our study subjects did not meet the positive standard as defined by the CDC surveillance criteria.” One must therefore wonder if their study subjects ever had Lyme disease in the first place.

References
Middleveen, MJ, Burke, J., Sapi, E., et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. [v1; ref status: awaiting peer review, http://f1000r.es/4rm] published 19 December 2014, F1000Research 2014, 3:309 (doi:10.12688/f1000 research.57778.1).

Moody, KD, and Barthold, SW. Relative infectivity of Borrelia burgdorferi in Lewis rats by varius routes of inoculation. Amer. J. Trop. Med. Hyg. 1991; 44: 135-139.

Woodrum, JE, and Oliver, JH Jr. Investigation of venereal, transplacental, and contact transmission of the Lyme disease sprirochete, Borrelia burgdorferi, in Syrian hamsters. J. Parasitol. 1999: 85, 426-430.

Wormser, GP, and O’Connell, S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert. Rev. Anti. Infect. Ther. 2011; 9: 245-260.

Williams, CL, Strobino, B, Weinstein, A. et al. Maternal Lyme disease; congenital malformations and a cord blood serosurvey in endemic and control areas. Paediatr. Perinat. Epidemiol. 1995; 180: 711-716.

Strobino, B, Abid, S, and Gewitz, M. Maternal Lyme disease and congential heart disease: a case control study in an endemic area. Am. J. Obstet. Gynecol. 199; 180: 711-716.

Elliot, DJ, Eppes, SC, and Klein, JD. Teratogen Update: Lyme disease. Teratology 2001; 64: 276-286.

http://www.cdc.gov/lyme/faq/#sexually
Competing Interests: No competing interests were disclosed. Close
Report a concern
Discussion is closed on this version, please comment on the latest version above.

Author details Author details

Competing interests

Grant information

Supported in part by a grant to MJM from the Lindorf Family Foundation, Newark, OH.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Article Versions (3)

version 3

Revised

Published: 27 Apr 2015, 3:309

https://doi.org/10.12688/f1000research.5778.3

version 2

Revised

Published: 20 Jan 2015, 3:309

https://doi.org/10.12688/f1000research.5778.2

version 1

Published: 18 Dec 2014, 3:309

https://doi.org/10.12688/f1000research.5778.1

© 2014 Middelveen MJ et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

SEE MORE DETAILS

CITE

how to cite this article

Middelveen MJ, Burke J, Sapi E et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions [version 1; peer review: 1 not approved]. F1000Research 2014, 3:309 (https://doi.org/10.12688/f1000research.5778.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Version 1

VERSION 1

PUBLISHED 18 Dec 2014

Views

822

Reviewer Report 05 Jan 2015

Sam T. Donta, Falmouth Hospital, Falmouth, MA, USA

Not Approved

https://doi.org/10.5256/f1000research.6178.r7090

There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

Specific issues in this report:

No evidence that samples were blinded.
The numbers of patients were too small from which to draw meaningful conclusions.
The actual serologic data on patients should be presented in order to be more properly assessed.
PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.
Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.
Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.
Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.
If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.
PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

Competing Interests: No competing interests were disclosed.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

CITE

Report a concern

Author Response 20 Jan 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

20 Jan 2015

Author Response
Co-written with Marianne J. Middelveen
- There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.
  
  We did not conclude that “Lyme disease can
... Continue reading
Co-written with Marianne J. Middelveen
There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

We did not conclude that “Lyme disease can be transmitted sexually”. Based on preliminary editorial comments, we were careful to state that our microscopy, immunochemistry, molecular hybridization and PCR analysis showing live, culturable Borrelia in semen and vaginal secretions suggests that these spirochetes could be transmitted in that manner. Our study does not prove this form of transmission, and we do not make this claim anywhere in the text.

While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

The statement that “better controlled” studies do not provide support for contact transmission of Borrelia in animals is contrary to the examples in mice and dogs described in the Introduction and Discussion sections of our article. We have pointed out that the two studies on highly inbred rodents that allegedly showed lack of such transmission did not use PCR techniques and therefore may have missed this transmission. The fact that the CDC now admits to more than 300,000 new cases of Lyme disease each year in the USA (and perhaps as many as one million new cases, as outlined in Stricker & Johnson, 2014) is suggestive that other forms of transmission occur, as noted in the Discussion section on page 10.

1. No evidence that samples were blinded. 

In response to the referee’s comment, we have noted that the laboratory testing was performed on coded samples in a blinded fashion. This has been noted in the Abstract and reiterated throughout the Methods section.

2. The numbers of patients were too small from which to draw meaningful conclusions.

The “meaningful conclusions” are that  microscopy, immunochemistry, molecular hybridization and PCR analysis demonstrates live, culturable Borrelia in semen and vaginal secretions from Lyme disease patients. Although the numbers are relatively small, we feel that our detailed study supports this conclusion.

3.The actual serologic data on patients should be presented in order to be more properly assessed.

We can include the actual serologic data as an original Dataset, but we don’t see how that would alter the experimental findings in our study. The serologic data is presented in Table 1 and the Results section. In response to the referee’s comment, we have added more detail about the serologic and diagnostic criteria in the Methods section on page 4, with supporting references.

4. PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.

PCR-DNA analysis was done on the “original specimens” in a blinded fashion  in conjunction with the microscopy, immunochemistry and molecular hybridization analysis. Repeated testing at weekly or other intervals is beyond the scope of this pilot study, and this type of testing should certainly be explored in future Lyme disease studies.

5. Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.

As shown in Table 5, we did do PCR testing on concurrent blood samples in some patients. Saliva testing for Borrelia would have been of interest, but this form of Borrelia testing requires further investigation and is beyond the scope of our study. 

6. Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.

In response to the referee’s comment, we have researched the number of spirochetes necessary for transmission of B. burgdorferi infection in mice and T. pallidum  infection in humans. The results show that a very small number of spirochetes (as little as 18 organisms) are required for transmission of infection, and we have included this information in the Discussion on page 11. We have also noted that seminal plasma and the female genital tract may provide a relatively permissive environment for spirochetes compared to blood, skin and other immune sites, making transmission theoretically easier via the genital route.

Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.

In response to the referee’s query, we have provided examples of other agents (Babesia, Chlamydia, Coxiella) that are proven or postulated to be transmitted by both tickbite and intimate contact. This information is included in the Discussion on page 11 with supporting references.

If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.

As noted above, the substantial numbers of  new Lyme disease cases each year suggests additional forms of transmission beyond a tickbite. At this time, the true epidemiology of Lyme disease is unknown because the CDC surveillance system only captures less than 10% of Lyme disease cases, as noted in the Discussion on page 11. Other epidemiological studies have suggested that some infected patients may be relatively asymptomatic (Harvey & Salvato, 2003), so transmission via intimate contact resulting in less obvious infection is plausible. The risk of this form of transmission and correlation with symptoms merits further study. Our report simply raises the possibility, and rejecting the report will shove this issue under the rug to the detriment of Lyme patients.

9. PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

PCR-DNA analysis is subject to contamination. That is why we did blinded testing that always included negative controls in three different laboratories using microscopy, immunochemistry and molecular hybridization to confirm the PCR findings. Although PCR testing alone might be “difficult to interpret”, the combination of experimental techniques done in different laboratories makes interpretation much more reliable.
We hope that the referee will change his opinion after reading the revised manuscript and our responses to his comments.
Co-written with Marianne J. Middelveen
There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

We did not conclude that “Lyme disease can be transmitted sexually”. Based on preliminary editorial comments, we were careful to state that our microscopy, immunochemistry, molecular hybridization and PCR analysis showing live, culturable Borrelia in semen and vaginal secretions suggests that these spirochetes could be transmitted in that manner. Our study does not prove this form of transmission, and we do not make this claim anywhere in the text.

While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

The statement that “better controlled” studies do not provide support for contact transmission of Borrelia in animals is contrary to the examples in mice and dogs described in the Introduction and Discussion sections of our article. We have pointed out that the two studies on highly inbred rodents that allegedly showed lack of such transmission did not use PCR techniques and therefore may have missed this transmission. The fact that the CDC now admits to more than 300,000 new cases of Lyme disease each year in the USA (and perhaps as many as one million new cases, as outlined in Stricker & Johnson, 2014) is suggestive that other forms of transmission occur, as noted in the Discussion section on page 10.

1. No evidence that samples were blinded. 

In response to the referee’s comment, we have noted that the laboratory testing was performed on coded samples in a blinded fashion. This has been noted in the Abstract and reiterated throughout the Methods section.

2. The numbers of patients were too small from which to draw meaningful conclusions.

The “meaningful conclusions” are that  microscopy, immunochemistry, molecular hybridization and PCR analysis demonstrates live, culturable Borrelia in semen and vaginal secretions from Lyme disease patients. Although the numbers are relatively small, we feel that our detailed study supports this conclusion.

3.The actual serologic data on patients should be presented in order to be more properly assessed.

We can include the actual serologic data as an original Dataset, but we don’t see how that would alter the experimental findings in our study. The serologic data is presented in Table 1 and the Results section. In response to the referee’s comment, we have added more detail about the serologic and diagnostic criteria in the Methods section on page 4, with supporting references.

4. PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.

PCR-DNA analysis was done on the “original specimens” in a blinded fashion  in conjunction with the microscopy, immunochemistry and molecular hybridization analysis. Repeated testing at weekly or other intervals is beyond the scope of this pilot study, and this type of testing should certainly be explored in future Lyme disease studies.

5. Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.

As shown in Table 5, we did do PCR testing on concurrent blood samples in some patients. Saliva testing for Borrelia would have been of interest, but this form of Borrelia testing requires further investigation and is beyond the scope of our study. 

6. Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.

In response to the referee’s comment, we have researched the number of spirochetes necessary for transmission of B. burgdorferi infection in mice and T. pallidum  infection in humans. The results show that a very small number of spirochetes (as little as 18 organisms) are required for transmission of infection, and we have included this information in the Discussion on page 11. We have also noted that seminal plasma and the female genital tract may provide a relatively permissive environment for spirochetes compared to blood, skin and other immune sites, making transmission theoretically easier via the genital route.

Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.

In response to the referee’s query, we have provided examples of other agents (Babesia, Chlamydia, Coxiella) that are proven or postulated to be transmitted by both tickbite and intimate contact. This information is included in the Discussion on page 11 with supporting references.

If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.

As noted above, the substantial numbers of  new Lyme disease cases each year suggests additional forms of transmission beyond a tickbite. At this time, the true epidemiology of Lyme disease is unknown because the CDC surveillance system only captures less than 10% of Lyme disease cases, as noted in the Discussion on page 11. Other epidemiological studies have suggested that some infected patients may be relatively asymptomatic (Harvey & Salvato, 2003), so transmission via intimate contact resulting in less obvious infection is plausible. The risk of this form of transmission and correlation with symptoms merits further study. Our report simply raises the possibility, and rejecting the report will shove this issue under the rug to the detriment of Lyme patients.

9. PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

PCR-DNA analysis is subject to contamination. That is why we did blinded testing that always included negative controls in three different laboratories using microscopy, immunochemistry and molecular hybridization to confirm the PCR findings. Although PCR testing alone might be “difficult to interpret”, the combination of experimental techniques done in different laboratories makes interpretation much more reliable.
We hope that the referee will change his opinion after reading the revised manuscript and our responses to his comments.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 20 Jan 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

20 Jan 2015

Author Response
Co-written with Marianne J. Middelveen
- There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.
  
  We did not conclude that “Lyme disease can
... Continue reading
Co-written with Marianne J. Middelveen
There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

We did not conclude that “Lyme disease can be transmitted sexually”. Based on preliminary editorial comments, we were careful to state that our microscopy, immunochemistry, molecular hybridization and PCR analysis showing live, culturable Borrelia in semen and vaginal secretions suggests that these spirochetes could be transmitted in that manner. Our study does not prove this form of transmission, and we do not make this claim anywhere in the text.

While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

The statement that “better controlled” studies do not provide support for contact transmission of Borrelia in animals is contrary to the examples in mice and dogs described in the Introduction and Discussion sections of our article. We have pointed out that the two studies on highly inbred rodents that allegedly showed lack of such transmission did not use PCR techniques and therefore may have missed this transmission. The fact that the CDC now admits to more than 300,000 new cases of Lyme disease each year in the USA (and perhaps as many as one million new cases, as outlined in Stricker & Johnson, 2014) is suggestive that other forms of transmission occur, as noted in the Discussion section on page 10.

1. No evidence that samples were blinded. 

In response to the referee’s comment, we have noted that the laboratory testing was performed on coded samples in a blinded fashion. This has been noted in the Abstract and reiterated throughout the Methods section.

2. The numbers of patients were too small from which to draw meaningful conclusions.

The “meaningful conclusions” are that  microscopy, immunochemistry, molecular hybridization and PCR analysis demonstrates live, culturable Borrelia in semen and vaginal secretions from Lyme disease patients. Although the numbers are relatively small, we feel that our detailed study supports this conclusion.

3.The actual serologic data on patients should be presented in order to be more properly assessed.

We can include the actual serologic data as an original Dataset, but we don’t see how that would alter the experimental findings in our study. The serologic data is presented in Table 1 and the Results section. In response to the referee’s comment, we have added more detail about the serologic and diagnostic criteria in the Methods section on page 4, with supporting references.

4. PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.

PCR-DNA analysis was done on the “original specimens” in a blinded fashion  in conjunction with the microscopy, immunochemistry and molecular hybridization analysis. Repeated testing at weekly or other intervals is beyond the scope of this pilot study, and this type of testing should certainly be explored in future Lyme disease studies.

5. Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.

As shown in Table 5, we did do PCR testing on concurrent blood samples in some patients. Saliva testing for Borrelia would have been of interest, but this form of Borrelia testing requires further investigation and is beyond the scope of our study. 

6. Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.

In response to the referee’s comment, we have researched the number of spirochetes necessary for transmission of B. burgdorferi infection in mice and T. pallidum  infection in humans. The results show that a very small number of spirochetes (as little as 18 organisms) are required for transmission of infection, and we have included this information in the Discussion on page 11. We have also noted that seminal plasma and the female genital tract may provide a relatively permissive environment for spirochetes compared to blood, skin and other immune sites, making transmission theoretically easier via the genital route.

Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.

In response to the referee’s query, we have provided examples of other agents (Babesia, Chlamydia, Coxiella) that are proven or postulated to be transmitted by both tickbite and intimate contact. This information is included in the Discussion on page 11 with supporting references.

If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.

As noted above, the substantial numbers of  new Lyme disease cases each year suggests additional forms of transmission beyond a tickbite. At this time, the true epidemiology of Lyme disease is unknown because the CDC surveillance system only captures less than 10% of Lyme disease cases, as noted in the Discussion on page 11. Other epidemiological studies have suggested that some infected patients may be relatively asymptomatic (Harvey & Salvato, 2003), so transmission via intimate contact resulting in less obvious infection is plausible. The risk of this form of transmission and correlation with symptoms merits further study. Our report simply raises the possibility, and rejecting the report will shove this issue under the rug to the detriment of Lyme patients.

9. PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

PCR-DNA analysis is subject to contamination. That is why we did blinded testing that always included negative controls in three different laboratories using microscopy, immunochemistry and molecular hybridization to confirm the PCR findings. Although PCR testing alone might be “difficult to interpret”, the combination of experimental techniques done in different laboratories makes interpretation much more reliable.
We hope that the referee will change his opinion after reading the revised manuscript and our responses to his comments.
Co-written with Marianne J. Middelveen
There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

We did not conclude that “Lyme disease can be transmitted sexually”. Based on preliminary editorial comments, we were careful to state that our microscopy, immunochemistry, molecular hybridization and PCR analysis showing live, culturable Borrelia in semen and vaginal secretions suggests that these spirochetes could be transmitted in that manner. Our study does not prove this form of transmission, and we do not make this claim anywhere in the text.

While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

The statement that “better controlled” studies do not provide support for contact transmission of Borrelia in animals is contrary to the examples in mice and dogs described in the Introduction and Discussion sections of our article. We have pointed out that the two studies on highly inbred rodents that allegedly showed lack of such transmission did not use PCR techniques and therefore may have missed this transmission. The fact that the CDC now admits to more than 300,000 new cases of Lyme disease each year in the USA (and perhaps as many as one million new cases, as outlined in Stricker & Johnson, 2014) is suggestive that other forms of transmission occur, as noted in the Discussion section on page 10.

1. No evidence that samples were blinded. 

In response to the referee’s comment, we have noted that the laboratory testing was performed on coded samples in a blinded fashion. This has been noted in the Abstract and reiterated throughout the Methods section.

2. The numbers of patients were too small from which to draw meaningful conclusions.

The “meaningful conclusions” are that  microscopy, immunochemistry, molecular hybridization and PCR analysis demonstrates live, culturable Borrelia in semen and vaginal secretions from Lyme disease patients. Although the numbers are relatively small, we feel that our detailed study supports this conclusion.

3.The actual serologic data on patients should be presented in order to be more properly assessed.

We can include the actual serologic data as an original Dataset, but we don’t see how that would alter the experimental findings in our study. The serologic data is presented in Table 1 and the Results section. In response to the referee’s comment, we have added more detail about the serologic and diagnostic criteria in the Methods section on page 4, with supporting references.

4. PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.

PCR-DNA analysis was done on the “original specimens” in a blinded fashion  in conjunction with the microscopy, immunochemistry and molecular hybridization analysis. Repeated testing at weekly or other intervals is beyond the scope of this pilot study, and this type of testing should certainly be explored in future Lyme disease studies.

5. Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.

As shown in Table 5, we did do PCR testing on concurrent blood samples in some patients. Saliva testing for Borrelia would have been of interest, but this form of Borrelia testing requires further investigation and is beyond the scope of our study. 

6. Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.

In response to the referee’s comment, we have researched the number of spirochetes necessary for transmission of B. burgdorferi infection in mice and T. pallidum  infection in humans. The results show that a very small number of spirochetes (as little as 18 organisms) are required for transmission of infection, and we have included this information in the Discussion on page 11. We have also noted that seminal plasma and the female genital tract may provide a relatively permissive environment for spirochetes compared to blood, skin and other immune sites, making transmission theoretically easier via the genital route.

Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.

In response to the referee’s query, we have provided examples of other agents (Babesia, Chlamydia, Coxiella) that are proven or postulated to be transmitted by both tickbite and intimate contact. This information is included in the Discussion on page 11 with supporting references.

If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.

As noted above, the substantial numbers of  new Lyme disease cases each year suggests additional forms of transmission beyond a tickbite. At this time, the true epidemiology of Lyme disease is unknown because the CDC surveillance system only captures less than 10% of Lyme disease cases, as noted in the Discussion on page 11. Other epidemiological studies have suggested that some infected patients may be relatively asymptomatic (Harvey & Salvato, 2003), so transmission via intimate contact resulting in less obvious infection is plausible. The risk of this form of transmission and correlation with symptoms merits further study. Our report simply raises the possibility, and rejecting the report will shove this issue under the rug to the detriment of Lyme patients.

9. PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

PCR-DNA analysis is subject to contamination. That is why we did blinded testing that always included negative controls in three different laboratories using microscopy, immunochemistry and molecular hybridization to confirm the PCR findings. Although PCR testing alone might be “difficult to interpret”, the combination of experimental techniques done in different laboratories makes interpretation much more reliable.
We hope that the referee will change his opinion after reading the revised manuscript and our responses to his comments.
Competing Interests: No competing interests were disclosed. Close
Report a concern

Comments on this article Comments (5)

Version 3

VERSION 3 PUBLISHED 27 Apr 2015

Revised

Comment

Version 1

VERSION 1 PUBLISHED 18 Dec 2014

Discussion is closed on this version, please comment on the latest version above.

Reader Comment 22 Jan 2015

Phillip Baker, American Lyme Disease Foundation, USA

22 Jan 2015

Reader Comment

Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps ... Continue reading Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps Dr. Stricker would like to offer an explanation as to how long -- if at all-- B. burgdorferi is likely to survive in such a "hostile" environment.
Since the optimal pH for the growth of Borrelia burgdorferi is pH 7.6 and the pH of vaginal secretions is quite acidic, ranging from pH 3.8 - pH 4.5, perhaps Dr. Stricker would like to offer an explanation as to how long -- if at all-- B. burgdorferi is likely to survive in such a "hostile" environment.
Competing Interests: None Close
Report a concern
Reader Comment 20 Jan 2015

Sin Hang Lee, Milford Molecular Diagnostics, USA

20 Jan 2015

Reader Comment

Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates¹ were published before ... Continue reading Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates[ref-1] were published before the discovery of antibodies. In fact, attempts to rely on the Widal test (an antibody test) to diagnose typhoid fever were rejected more than 100 years ago[ref-2]. A CDC document clearly states that serology tests are not reliable for the diagnosis of typhoid fever[ref-3]. If the Koch’s postulates are to be applied in the diagnosis of Lyme disease, alternative methods, e.g. DNA sequencing-based tests[ref-4], to detect causative agents must be used.

[References]
[[1|title=Untersuchungen Über die Aetiologie der Wundinfectionskrankheiten|authors=Koch/R|vol= Leipzig: F.C.W. Vogel|year=1878]]
[[2|title=Zur Ätiologie und Pathogenese des Abdominaltyphus|authors=Jürgens/GJ|vol=Ztschr. f. klin. Med., Berl.|year=1904]]
[[3|title=Chapter 3 Infectious Diseases Related To Travel: Typhoid & Paratyphoid Fever In CDC Health Information for International Travel|authors=Newton/AE;Mintz/E |source=CDC|year=August 01, 2013|url=http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/typhoid-and-paratyphoid-fever]]
[[4|title=DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections|authors=Lee/SH;Vigliotti/JS;Vigliotti/VS;Jones/W;Moorcroft/TA;Lantsman/K|source=Int J Mol Sci|vol=15|issue=7|year=2014|fpage=11364|lpage=11386|type=journal|doi=10.3390/ijms150711364|pmid=24968274]]
Dr. Baker’s comment linking Koch’s postulates to the CDC Lyme disease case criteria which is based on the two-tier serology test results is not appropriate. The Koch's postulates¹ were published before the discovery of antibodies. In fact, attempts to rely on the Widal test (an antibody test) to diagnose typhoid fever were rejected more than 100 years ago². A CDC document clearly states that serology tests are not reliable for the diagnosis of typhoid fever³. If the Koch’s postulates are to be applied in the diagnosis of Lyme disease, alternative methods, e.g. DNA sequencing-based tests⁴, to detect causative agents must be used.

References
1. Koch R: Untersuchungen Über die Aetiologie der Wundinfectionskrankheiten. 1878; Leipzig: F.C.W. Vogel.
2. Jürgens GJ: Zur Ätiologie und Pathogenese des Abdominaltyphus. 1904; Ztschr. f. klin. Med., Berl..
3. Newton AE, Mintz E: Chapter 3 Infectious Diseases Related To Travel: Typhoid & Paratyphoid Fever In CDC Health Information for International Travel. CDC. August 01, 2013. Reference Source
4. Lee SH, Vigliotti JS, Vigliotti VS, Jones W, et al.: DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections. Int J Mol Sci. 2014; 15 (7): 11364-11386 PubMed Abstract | Publisher Full Text
Competing Interests: Competing Interests: Dr. Sin Hang Lee is the director of Milford Molecular Diagnostics, a CLIA-certified laboratory offering DNA sequencing-based tests for Lyme and related borrelioses Close
Report a concern
Reader Comment 12 Jan 2015

Phillip Baker, American Lyme Disease Foundation, USA

12 Jan 2015

Reader Comment

Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and ... Continue reading Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and vaginal secretions, if that finding indeed can be confirmed independently by other investigators, does not prove that they cause disease, especially in view of the fact that most of the patients examined were not seropositive by standard CDC test criteria. Perhaps Dr. Stricker ought to review Koch's postulates for guidance in that regard. In the absence of such proof, it is irresponsible and not in the best interest of the public health for Dr. Stricker to alarm the public by touting the results of preliminary and unconfirmed findings in the press.

Most recent data from the CDC still continue to show that, unlike the reported incidence of sexually transmitted diseases, reported cases of Lyme disease are concentrated in the same 13 States as in previous years. Obviously, the epidemiology is the same whether the reported number of cases is 30K or 300K per year.
Despite Dr. Stricker's attempts to obfuscate the key issues, the fact remains -- as noted by Donta in his review - that the mere presence of Borrelia in seminal and vaginal secretions, if that finding indeed can be confirmed independently by other investigators, does not prove that they cause disease, especially in view of the fact that most of the patients examined were not seropositive by standard CDC test criteria. Perhaps Dr. Stricker ought to review Koch's postulates for guidance in that regard. In the absence of such proof, it is irresponsible and not in the best interest of the public health for Dr. Stricker to alarm the public by touting the results of preliminary and unconfirmed findings in the press.

Most recent data from the CDC still continue to show that, unlike the reported incidence of sexually transmitted diseases, reported cases of Lyme disease are concentrated in the same 13 States as in previous years. Obviously, the epidemiology is the same whether the reported number of cases is 30K or 300K per year.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Author Response 07 Jan 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

07 Jan 2015

Author Response

Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, ... Continue reading Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, immunochemistry, molecular hybridization and polymerase chain reaction (PCR) techniques to demonstrate the presence of these live spirochetes in cultures of genital secretions, and as stated in the study our results suggest that Lyme disease could be sexually transmitted. All of the concerns in Baker’s commentary were previously aired on the Internet, and these concerns were addressed in our report. His objection has little merit for the reasons described below.

Baker represents a group of researchers who cling to the concept that Lyme disease is a trivial illness that is "hard to catch and easy to cure", and that chronic Lyme disease due to persistent infection with the Lyme spirochete, Borrelia burgdorferi, is rare or non-existent[ref-1]^,[ref-2]. As discussed elsewhere, this "Lyme denialist" philosophy and disregard for opposing viewpoints has been a major factor in the epidemic spread of Lyme disease, which accounts for more than 300,000 new cases per year in the USA according to the latest Centers for Disease Control and Prevention (CDC) estimates[ref-2]. As stated in our article, this alarming epidemic is twice as common as breast cancer and six times more common than HIV/AIDS, and its prevalence is hard to explain by tickbite transmission alone. Thus from an epidemiological perspective, sexual transmission of the live Borrelia spirochetes found in genital secretions is a plausible mechanism for the spread of Lyme disease.

Baker's commentary on our article uses selective information that supports his point of view while ignoring contradictory evidence. He starts with two animal models that appear to refute contact or sexual transmission of Lyme disease, and he concludes with selective epidemiological evidence from the CDC that obliquely supports his view. Sandwiched in between is a flawed discussion of maternal-fetal transmission of Lyme disease that has no bearing on sexual transmission of the spirochetal infection. Although we have addressed the animal model and epidemiological issues in our article, we will address these issues in greater detail below. We will leave it to readers to find the flaws in Baker's denial of maternal-fetal transmission of Lyme disease, since this form of transmission has been documented in canine, bovine, murine and human reports from the peer-reviewed medical literature[ref-3]^-[ref-8].

Baker cites two animal studies as proof that Lyme disease cannot be sexually transmitted[ref-9]^,[ref-10]. The study by Moody and Barthold was performed using Lewis rats, while the study by Woodrum and Oliver was performed using Syrian hamsters. In limiting his analysis to these two studies, Baker ignores the compelling observations in mice, birds, cats and dogs that support contact or sexual transmission of Lyme disease without a tick vector, as outlined in our report[ref-4]^,[ref-11]^-[ref-13]. The Lewis rat and Syrian hamster studies had significant flaws. First, these rodents are highly inbred with all Lewis rats descended from a single breeding colony, and all Syrian hamsters descended from a single female breeder[ref-14]^,[ref-15]. The effect of inbreeding on contact transmission of Borrelia is unknown. Second, these rodents are poor models for human Lyme disease. The Lewis rat develops a transient arthritis that fades without treatment following intraperitoneal injection of Borrelia, while the Syrian hamster may be colonized by Borrelia for long periods without showing any signs of disease[ref-16]^,[ref-17]. Since the disease pattern in these animals differs significantly from the human pattern, it is not surprising that transmission of Borrelia would differ as well. In fact, the immunocompetent Syrian hamster has been abandoned as a model for human Lyme disease because of these differences. Third and perhaps most important, both studies used limited culture and immunological methods to determine sexual transmission of Borrelia, and more sensitive detection of spirochetes by molecular techniques might have yielded positive results, as shown in other rodent experiments using PCR[ref-4]. Thus the selective animal models cited by Baker fail to refute the possibility of sexual transmission of Lyme disease in humans.

Baker attempts to use CDC surveillance statistics to further disprove sexual transmission of Lyme disease. He points to the fact that 95% of reported CDC surveillance cases occur in 12 states in the USA, and that these reported cases are seasonal and have a male and child predominance. As pointed out in our article, however, CDC surveillance cases account for less than 10% of total Lyme cases (about 30,000 cases out of more than 300,000 annual cases in the USA). Thus the epidemiology of the vast majority of Lyme cases is not covered by CDC surveillance reporting and may differ significantly from the epidemiology reported by the CDC. To support this view, as noted in our study, a recent report from Australia found that the prevalence of Lyme disease cases aligned with the sexually active population on that continent[ref-18]. Baker also questions whether our Lyme disease testing was accurate since it differs from the serological parameters used for CDC surveillance criteria. However the CDC surveillance criteria rely on testing that misses more than half of Lyme disease cases[ref-19], and these criteria are not recommended for diagnosis of Lyme disease[ref-20]. The reason why Baker thinks that insensitive and incomplete epidemiology statistics trump microscopy, immunochemistry, molecular hybridization and PCR testing that demonstrates live, culturable Borrelia spirochetes in genital secretions from our Lyme disease patients is unclear.

Baker bemoans the fact that because of the inconvenient evidence presented in our study, Lyme disease patients may suddenly be concerned about sexual transmission of their disease. Because Baker does not represent or treat patients, he may be unaware that this question is being asked by patients in clinicians’ offices every day as spouses and sexual partners become symptomatic. Should Lyme disease patients be concerned about sexual transmission? Absolutely. We currently treat Lyme disease with 60-year-old antibiotics that are marginally effective against a chronic infectious disease[ref-1]^,[ref-21]. Baker and his research associates should focus on the risk of sexual transmission of Borrelia and strive to develop new treatments for this alarming epidemic infection along the lines of the global "Manhattan Project" that has successfully dealt with the HIV/AIDS epidemic[ref-2]^,[ref-19]. Our suffering Lyme disease patients deserve nothing less.

[References]
[[1|title=Lyme disease: The next decade|authors=Stricker/RB;Johnson/L|source= Infect Drug Resist|vol=4|year=2011|fpage=1|lpage=9|type=journal|pmid=21694904|pmcid= PMC3108755]]
[[2|title=Lyme disease: Call for a “Manhattan Project” to combat the epidemic|authors=Stricker/RB;Johnson/L|source=PLoS Pathog|vol=10|issue=1|year=2014|fpage=e1003796|type=Journal|doi=10.1371/journal.ppat.1003796|pmid=24391491|pmcid=PMC3879353]]
[[3|title=Intrauterine transmission of Borrelia burgdorferi in dogs|authors=Gustafson/JM;Burgess/EC;Wachal/MD;Steinberg/H|source=Am J Vet Res|vol=54|issue=6|year=1993|fpage=882|lpage=890|type=journal|pmid= 8323057]]
[[4|title=Borrelia burgdorferi infection in dairy cows, rodents, and birds from four Wisconsin dairy farms|authors=Burgess/EC;Wachal/MD;Cleven/TD|source=Vet Microbiol|vol=35|issue=1-2|year=1993|fpage=61|lpage=77|type=journal|pmid=8362496]]
[[5|title=Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi|authors=Schlesinger/PA;Duray/PH;Burke/BA;Steere/AC;Stillman/MT|source= Ann Intern Med|vol=103|issue=1|year=1985|fpage=67|lpage=68|type=journal|pmid=4003991]]
[[6|title=Lyme Borrelia positive serology associated with spontaneous abortion in an endemic Italian area|authors=Carlomagno/G;Luksa/V;Candussi/G;Rizzi/GM;Trevisan/G|source=Acta Eur Fertil|vol=19|issue=5|year=1988|fpage=279|lpage=281|type=Journal|pmid=3252658]]
[[7|title=Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy|authors=Weber/K;Bratzke/HJ;Neubert/U;Wilske/B;Duray/PH|source=Pediatr Infect Dis J|vol=7|issue=4|year=1988|fpage=286|lpage=289|type=journal|pmid=3130607]]
[[8|title=Gestational Lyme borreliosis: implications for the fetus|authors=MacDonald/AB|source=Rheum Dis Clin North Am|vol=15|issue=4|year=1989|fpage=657|lpage=677|type=journal|pmid=2685924]]
[[9|title=Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation|authors=Moody/KD;Barthold/SW|source= Am J Trop Med Hyg|vol=44|issue=2|year=1991|fpage=135|lpage=139|type=journal|pmid=2012256]]
[[10|title=Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters|authors=Woodrum/JE;Oliver/JH|source=J Parasitol|vol=85|issue=3|year=1999|fpage=426|lpage=430|type=journal|pmid=10386432]]
[[11|title=Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: Evidence of contact transmission|authors=Burgess/EC;Amundson/TE;Davis/JP;Kaslow/RA;Edelman/R|source=Am J Trop Med Hyg|vol=35|issue=2|year=1986|fpage=355|lpage=359|type=journal|pmid=3513648]]
[[12|title=Experimental infection of the white-footed mouse with Borrelia burgdorferi|authors=Wright/SD;Nielsen/SW|source=Am J Vet Res|vol=51|issue=12|year=1990|fpage=1980|lpage=1987|type=journal|pmid=2085225]]
[[13|title=The in utero and seminal transmission of Borrelia burgdorferi in Canidae (PhD thesis, University of Wisconsin, Madison; Accessed: December 30, 2014)|authors=Gustafson/JM|year=1993|url=http://search.library.wisc.edu/catalog/ocm29551629]]
[[14|title=Lewis rat (Accessed: December 30, 2014)|source=Wikipedia|url=http://en.wikipedia.org/wiki/Laboratory_rat]]
[[15|title=Golden hamster (Accessed: December 30, 2014)|source=Wikipedia|url=http://en.wikipedia.org/wiki/Golden_hamster]]
[[16|title=Experimental chronic Lyme borreliosis in Lewis rats|authors=Moody/KD;Barthold/SW;Terwilliger/GA;Beck/DS;Hansen/GM;Jacoby/RO|source=Am J Trop Med Hyg|vol=42|issue=2|year=1990|fpage=165|lpage=174|type=journal|pmid=2138431]]
[[17|title=Experimental infection of the hamster with Borrelia burgdorferi|authors=Johnson/RC;Codner/C;Russell/M;Duray/PH|source=Ann N Y Acad Sci|vol=539|year=1988|fpage=258|lpage=263|type=journal|doi=10.1111/j.1749-6632.1988.tb31859.x]]
[[18|title=Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort|authors=Mayne/PJ|source=Int J Gen Med|vol=8|year=2015|fpage=15|lpage=26|type=journal|doi=10.2147/IJGM.S75825|url= http://www.dovepress.com/clinical-determinants-of-lyme-borreliosis-babesiosis-bartonellosis-ana-peer-reviewed-article-IJGM#]]
[[19|title=Lyme disease diagnosis and treatment: lessons from the AIDS epidemic|authors=Stricker/RB;Johnson/L|source=Minerva Med|vol=101|issue=6|year=2010|fpage=419|lpage=425|type=journal|pmid=21196901]]
[[20|title= Lyme disease: 2011 case definition (Accessed: December 30, 2014)|source=CDC|url=http://wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrID=752andDatePub=1/1/2011%2012:00:00%20AM.]]
[[21|title=Relevance of chronic Lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review|authors=Borgermans/L;Goderis/G;Vandevoorde/J;Devroey/D|source=Int J Family Med|vol=2014|year=2014|type=journal|doi=10.1155/2014/138016|url=http://www.hindawi.com/journals/ijfm/2014/138016/]]
Co-written with Marianne J. Middelveen

We appreciate Phillip Baker's interest in our study showing live, culturable Borrelia spirochetes in semen and vaginal secretions from patients with Lyme disease. We used microscopy, immunochemistry, molecular hybridization and polymerase chain reaction (PCR) techniques to demonstrate the presence of these live spirochetes in cultures of genital secretions, and as stated in the study our results suggest that Lyme disease could be sexually transmitted. All of the concerns in Baker’s commentary were previously aired on the Internet, and these concerns were addressed in our report. His objection has little merit for the reasons described below.

Baker represents a group of researchers who cling to the concept that Lyme disease is a trivial illness that is "hard to catch and easy to cure", and that chronic Lyme disease due to persistent infection with the Lyme spirochete, Borrelia burgdorferi, is rare or non-existent¹^,². As discussed elsewhere, this "Lyme denialist" philosophy and disregard for opposing viewpoints has been a major factor in the epidemic spread of Lyme disease, which accounts for more than 300,000 new cases per year in the USA according to the latest Centers for Disease Control and Prevention (CDC) estimates². As stated in our article, this alarming epidemic is twice as common as breast cancer and six times more common than HIV/AIDS, and its prevalence is hard to explain by tickbite transmission alone. Thus from an epidemiological perspective, sexual transmission of the live Borrelia spirochetes found in genital secretions is a plausible mechanism for the spread of Lyme disease.

Baker's commentary on our article uses selective information that supports his point of view while ignoring contradictory evidence. He starts with two animal models that appear to refute contact or sexual transmission of Lyme disease, and he concludes with selective epidemiological evidence from the CDC that obliquely supports his view. Sandwiched in between is a flawed discussion of maternal-fetal transmission of Lyme disease that has no bearing on sexual transmission of the spirochetal infection. Although we have addressed the animal model and epidemiological issues in our article, we will address these issues in greater detail below. We will leave it to readers to find the flaws in Baker's denial of maternal-fetal transmission of Lyme disease, since this form of transmission has been documented in canine, bovine, murine and human reports from the peer-reviewed medical literature³^-⁸.

Baker cites two animal studies as proof that Lyme disease cannot be sexually transmitted⁹^,¹⁰. The study by Moody and Barthold was performed using Lewis rats, while the study by Woodrum and Oliver was performed using Syrian hamsters. In limiting his analysis to these two studies, Baker ignores the compelling observations in mice, birds, cats and dogs that support contact or sexual transmission of Lyme disease without a tick vector, as outlined in our report⁴^,¹¹^-¹³. The Lewis rat and Syrian hamster studies had significant flaws. First, these rodents are highly inbred with all Lewis rats descended from a single breeding colony, and all Syrian hamsters descended from a single female breeder¹⁴^,¹⁵. The effect of inbreeding on contact transmission of Borrelia is unknown. Second, these rodents are poor models for human Lyme disease. The Lewis rat develops a transient arthritis that fades without treatment following intraperitoneal injection of Borrelia, while the Syrian hamster may be colonized by Borrelia for long periods without showing any signs of disease¹⁶^,¹⁷. Since the disease pattern in these animals differs significantly from the human pattern, it is not surprising that transmission of Borrelia would differ as well. In fact, the immunocompetent Syrian hamster has been abandoned as a model for human Lyme disease because of these differences. Third and perhaps most important, both studies used limited culture and immunological methods to determine sexual transmission of Borrelia, and more sensitive detection of spirochetes by molecular techniques might have yielded positive results, as shown in other rodent experiments using PCR⁴. Thus the selective animal models cited by Baker fail to refute the possibility of sexual transmission of Lyme disease in humans.

Baker attempts to use CDC surveillance statistics to further disprove sexual transmission of Lyme disease. He points to the fact that 95% of reported CDC surveillance cases occur in 12 states in the USA, and that these reported cases are seasonal and have a male and child predominance. As pointed out in our article, however, CDC surveillance cases account for less than 10% of total Lyme cases (about 30,000 cases out of more than 300,000 annual cases in the USA). Thus the epidemiology of the vast majority of Lyme cases is not covered by CDC surveillance reporting and may differ significantly from the epidemiology reported by the CDC. To support this view, as noted in our study, a recent report from Australia found that the prevalence of Lyme disease cases aligned with the sexually active population on that continent¹⁸. Baker also questions whether our Lyme disease testing was accurate since it differs from the serological parameters used for CDC surveillance criteria. However the CDC surveillance criteria rely on testing that misses more than half of Lyme disease cases¹⁹, and these criteria are not recommended for diagnosis of Lyme disease²⁰. The reason why Baker thinks that insensitive and incomplete epidemiology statistics trump microscopy, immunochemistry, molecular hybridization and PCR testing that demonstrates live, culturable Borrelia spirochetes in genital secretions from our Lyme disease patients is unclear.

Baker bemoans the fact that because of the inconvenient evidence presented in our study, Lyme disease patients may suddenly be concerned about sexual transmission of their disease. Because Baker does not represent or treat patients, he may be unaware that this question is being asked by patients in clinicians’ offices every day as spouses and sexual partners become symptomatic. Should Lyme disease patients be concerned about sexual transmission? Absolutely. We currently treat Lyme disease with 60-year-old antibiotics that are marginally effective against a chronic infectious disease¹^,²¹. Baker and his research associates should focus on the risk of sexual transmission of Borrelia and strive to develop new treatments for this alarming epidemic infection along the lines of the global "Manhattan Project" that has successfully dealt with the HIV/AIDS epidemic²^,¹⁹. Our suffering Lyme disease patients deserve nothing less.

References
1. Stricker RB, Johnson L: Lyme disease: The next decade. Infect Drug Resist. 2011; 4: 1-9 PubMed Abstract | Free Full Text
2. Stricker RB, Johnson L: Lyme disease: Call for a “Manhattan Project” to combat the epidemic. PLoS Pathog. 2014; 10 (1): e1003796 PubMed Abstract | Free Full Text | Publisher Full Text
3. Gustafson JM, Burgess EC, Wachal MD, Steinberg H: Intrauterine transmission of Borrelia burgdorferi in dogs. Am J Vet Res. 1993; 54 (6): 882-890 PubMed Abstract
4. Burgess EC, Wachal MD, Cleven TD: Borrelia burgdorferi infection in dairy cows, rodents, and birds from four Wisconsin dairy farms. Vet Microbiol. 1993; 35 (1-2): 61-77 PubMed Abstract
5. Schlesinger PA, Duray PH, Burke BA, Steere AC, et al.: Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med. 1985; 103 (1): 67-68 PubMed Abstract
6. Carlomagno G, Luksa V, Candussi G, Rizzi GM, et al.: Lyme Borrelia positive serology associated with spontaneous abortion in an endemic Italian area. Acta Eur Fertil. 1988; 19 (5): 279-281 PubMed Abstract
7. Weber K, Bratzke HJ, Neubert U, Wilske B, et al.: Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J. 1988; 7 (4): 286-289 PubMed Abstract
8. MacDonald AB: Gestational Lyme borreliosis: implications for the fetus. Rheum Dis Clin North Am. 1989; 15 (4): 657-677 PubMed Abstract
9. Moody KD, Barthold SW: Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Am J Trop Med Hyg. 1991; 44 (2): 135-139 PubMed Abstract
10. Woodrum JE, Oliver JH: Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol. 1999; 85 (3): 426-430 PubMed Abstract
11. Burgess EC, Amundson TE, Davis JP, Kaslow RA, et al.: Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: Evidence of contact transmission. Am J Trop Med Hyg. 1986; 35 (2): 355-359 PubMed Abstract
12. Wright SD, Nielsen SW: Experimental infection of the white-footed mouse with Borrelia burgdorferi. Am J Vet Res. 1990; 51 (12): 1980-1987 PubMed Abstract
13. Gustafson JM: The in utero and seminal transmission of Borrelia burgdorferi in Canidae (PhD thesis, University of Wisconsin, Madison; Accessed: December 30, 2014). 1993. Reference Source
14. Lewis rat (Accessed: December 30, 2014). Wikipedia. Reference Source
15. Golden hamster (Accessed: December 30, 2014). Wikipedia. Reference Source
16. Moody KD, Barthold SW, Terwilliger GA, Beck DS, et al.: Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg. 1990; 42 (2): 165-174 PubMed Abstract
17. Johnson RC, Codner C, Russell M, Duray PH: Experimental infection of the hamster with Borrelia burgdorferi. Ann N Y Acad Sci. 1988; 539: 258-263 Publisher Full Text
18. Mayne PJ: Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort. Int J Gen Med. 2015; 8: 15-26 Publisher Full Text | Reference Source
19. Stricker RB, Johnson L: Lyme disease diagnosis and treatment: lessons from the AIDS epidemic. Minerva Med. 2010; 101 (6): 419-425 PubMed Abstract
20. Lyme disease: 2011 case definition (Accessed: December 30, 2014). CDC. Reference Source
21. Borgermans L, Goderis G, Vandevoorde J, Devroey D: Relevance of chronic Lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review. Int J Family Med. 2014; 2014. Publisher Full Text | Reference Source
Competing Interests: None Close
Report a concern
Reader Comment 29 Dec 2014

Phillip Baker, American Lyme Disease Foundation, USA

29 Dec 2014

Reader Comment
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold ... Continue reading
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold², as well as Woodrum and Oliver³, internationally known experts on Lyme disease. These investigators used well-characterized animal models of borreliosis in which infection is much more disseminated and profound than it ever is in humans. It should be noted that, in the United States, Lyme borreliosis has historically been defined as a tick borne infection caused by Borrelia burgdorferi sensu lato⁴.

To determine if borreliosis can be transmitted by direct contact, Moody and Barthold ² housed three-day-old - or three-week-old- Lewis rats, deliberately infected with B. burgdorferi, with normal, uninfected rats for 30 days. As expected, all deliberately infected rats continued to be actively infected, 30 days later; however, none of the uninfected rats acquired infection after 30 days of intimate direct contact with their
infected house mates.

In other experiments, Moody and Barthold ²were unable to demonstrate venereal transmission of borreliosis from seven infected females-or six infected males - to uninfected rats of the opposite sex.

In the work of Woodrum and Oliver ³, six female Syrian hamsters infected with B.burgdorferi were mated with six uninfected males; conversely, three infected males were mated with six uninfected females. None of the uninfected hamsters became infected after mating with an infected partner of the opposite sex, indicating that borreliosis is not sexually transmitted. These investigators also failed to demonstrate contact transmission of B. burgdorferi between infected female -or male-hamsters and uninfected hamsters of the opposite sex. Also, it was not possible to transmit borreliosis to uninfected hamsters with urine or feces from infected hamsters.

Sadly, preliminary oral reports of the observations of Middelveen et al.¹ have already generated an inordinate amount of fear and anxiety within the lay community due to sensationalized reports of their unconfirmed findings by an uncritical - and often naïve - press. This has already caused much harm. To date, I have received numerous inquiries from distraught individuals, wondering if they now should even consider marrying their spouse-to-be for fear of contracting Lyme disease that some mistakenly believe to be incurable. Some fear the possibility of giving birth to an infected or congenitally deformed child, because their spouse or spouse-to-be had been diagnosed and treated for Lyme disease in the past.

To examine the issue of in utero transmission of infection, Moody and Barthold ² inoculated pregnant female Lewis rats with viable B. burgdorferi, at four days of gestation. All of the inoculated pregnant females became seropositive as expected, and B. burgdorferi could be cultured from their spleens at 20 days of gestation; however, their placentas and fetuses were culture negative, indicting the lack of in utero transmission.

Moody and Barthold ² used two different experimental protocols to determine if transplacental transmission of B. burgdorferi occurs. One protocol involved six non-pregnant infected females that were subsequently mated and became pregnant. Three of the females were allowed to carry to full term, whereas the remaining three were sacrificed just prior to parturition. All offspring and offspring-to-be were found to be culture negative for B. burgdorferi, as well as seronegative for antibody specific for B. burgdorferi, indicating that transplacental transmission of infection does not occur.

In the second protocol, six females were infected via tick bite after becoming pregnant, and were allowed to carry their fetuses to birth; all were negative for infection. The results of these studies likewise failed to provide evidence for the transplacental transmission of naturally acquired borreliosis.

Other investigators examined the possibility of congenital birth defects in humans with Lyme disease by doing a rather large comparative study involving 5,000 infants, half from an area in which Lyme disease was endemic and half as controls from an area without Lyme disease ⁵. They found no significant differences in the overall incidence of congenital malformations between the two groups.

In another study, involving 1,500 subjects including controls, no increased risk of giving birth to a child with a congenital heart defect was noted in women who had either been bitten by a tick or had been treated for Lyme disease during or before pregnancy ⁶.

Finally, an extensive analysis of the world literature revealed “that an adverse outcome due to maternal infection with B. burgdorferi at any point during pregnancy in humans is at most extremely rare” ⁷.

In view of the above considerations, the work by Middelveen et al. ¹ is not credible and must be view with much skepticism. There is no evidence to indicate that vaginal and seminal secretions provide a suitable environment for the growth of Borrelia ⁸ and that the mere presence of Borrelia in vaginal and seminal secretions – if such an observation is indeed valid and can be confirmed independently – results in disease. In the absence of such proof, no conclusions can be drawn as to the sexual transmission of Lyme disease by of B. burgdorferi.

Addendum added in proof:

It should be noted that the basic epidemiology of vector-borne Lyme disease is strikingly different from that for sexually transmitted diseases (STDs). For example, annual data provided by the CDC indicate that about 95% of all reported cases of Lyme disease occur in 12 States, and the incidence of Lyme disease is seasonal and peaks with increased tick activity. Also, in the case of STDs, there are more husband-wife paired cases rather than the preponderance of cases of males and children with Lyme disease. Most important, Middelveen et al. state that “… the majority of our study subjects did not meet the positive standard as defined by the CDC surveillance criteria.” One must therefore wonder if their study subjects ever had Lyme disease in the first place.

References
Middleveen, MJ, Burke, J., Sapi, E., et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. [v1; ref status: awaiting peer review, http://f1000r.es/4rm] published 19 December 2014, F1000Research 2014, 3:309 (doi:10.12688/f1000 research.57778.1).

Moody, KD, and Barthold, SW. Relative infectivity of Borrelia burgdorferi in Lewis rats by varius routes of inoculation. Amer. J. Trop. Med. Hyg. 1991; 44: 135-139.

Woodrum, JE, and Oliver, JH Jr. Investigation of venereal, transplacental, and contact transmission of the Lyme disease sprirochete, Borrelia burgdorferi, in Syrian hamsters. J. Parasitol. 1999: 85, 426-430.

Wormser, GP, and O’Connell, S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert. Rev. Anti. Infect. Ther. 2011; 9: 245-260.

Williams, CL, Strobino, B, Weinstein, A. et al. Maternal Lyme disease; congenital malformations and a cord blood serosurvey in endemic and control areas. Paediatr. Perinat. Epidemiol. 1995; 180: 711-716.

Strobino, B, Abid, S, and Gewitz, M. Maternal Lyme disease and congential heart disease: a case control study in an endemic area. Am. J. Obstet. Gynecol. 199; 180: 711-716.

Elliot, DJ, Eppes, SC, and Klein, JD. Teratogen Update: Lyme disease. Teratology 2001; 64: 276-286.

http://www.cdc.gov/lyme/faq/#sexually
The concept of sexual transmission of borreliosis, which has been resurrected recently by Middelveen et al.¹, was refuted years ago by the well-designed and controlled studies of Moody and Barthold², as well as Woodrum and Oliver³, internationally known experts on Lyme disease. These investigators used well-characterized animal models of borreliosis in which infection is much more disseminated and profound than it ever is in humans. It should be noted that, in the United States, Lyme borreliosis has historically been defined as a tick borne infection caused by Borrelia burgdorferi sensu lato⁴.

To determine if borreliosis can be transmitted by direct contact, Moody and Barthold ² housed three-day-old - or three-week-old- Lewis rats, deliberately infected with B. burgdorferi, with normal, uninfected rats for 30 days. As expected, all deliberately infected rats continued to be actively infected, 30 days later; however, none of the uninfected rats acquired infection after 30 days of intimate direct contact with their
infected house mates.

In other experiments, Moody and Barthold ²were unable to demonstrate venereal transmission of borreliosis from seven infected females-or six infected males - to uninfected rats of the opposite sex.

In the work of Woodrum and Oliver ³, six female Syrian hamsters infected with B.burgdorferi were mated with six uninfected males; conversely, three infected males were mated with six uninfected females. None of the uninfected hamsters became infected after mating with an infected partner of the opposite sex, indicating that borreliosis is not sexually transmitted. These investigators also failed to demonstrate contact transmission of B. burgdorferi between infected female -or male-hamsters and uninfected hamsters of the opposite sex. Also, it was not possible to transmit borreliosis to uninfected hamsters with urine or feces from infected hamsters.

Sadly, preliminary oral reports of the observations of Middelveen et al.¹ have already generated an inordinate amount of fear and anxiety within the lay community due to sensationalized reports of their unconfirmed findings by an uncritical - and often naïve - press. This has already caused much harm. To date, I have received numerous inquiries from distraught individuals, wondering if they now should even consider marrying their spouse-to-be for fear of contracting Lyme disease that some mistakenly believe to be incurable. Some fear the possibility of giving birth to an infected or congenitally deformed child, because their spouse or spouse-to-be had been diagnosed and treated for Lyme disease in the past.

To examine the issue of in utero transmission of infection, Moody and Barthold ² inoculated pregnant female Lewis rats with viable B. burgdorferi, at four days of gestation. All of the inoculated pregnant females became seropositive as expected, and B. burgdorferi could be cultured from their spleens at 20 days of gestation; however, their placentas and fetuses were culture negative, indicting the lack of in utero transmission.

Moody and Barthold ² used two different experimental protocols to determine if transplacental transmission of B. burgdorferi occurs. One protocol involved six non-pregnant infected females that were subsequently mated and became pregnant. Three of the females were allowed to carry to full term, whereas the remaining three were sacrificed just prior to parturition. All offspring and offspring-to-be were found to be culture negative for B. burgdorferi, as well as seronegative for antibody specific for B. burgdorferi, indicating that transplacental transmission of infection does not occur.

In the second protocol, six females were infected via tick bite after becoming pregnant, and were allowed to carry their fetuses to birth; all were negative for infection. The results of these studies likewise failed to provide evidence for the transplacental transmission of naturally acquired borreliosis.

Other investigators examined the possibility of congenital birth defects in humans with Lyme disease by doing a rather large comparative study involving 5,000 infants, half from an area in which Lyme disease was endemic and half as controls from an area without Lyme disease ⁵. They found no significant differences in the overall incidence of congenital malformations between the two groups.

In another study, involving 1,500 subjects including controls, no increased risk of giving birth to a child with a congenital heart defect was noted in women who had either been bitten by a tick or had been treated for Lyme disease during or before pregnancy ⁶.

Finally, an extensive analysis of the world literature revealed “that an adverse outcome due to maternal infection with B. burgdorferi at any point during pregnancy in humans is at most extremely rare” ⁷.

In view of the above considerations, the work by Middelveen et al. ¹ is not credible and must be view with much skepticism. There is no evidence to indicate that vaginal and seminal secretions provide a suitable environment for the growth of Borrelia ⁸ and that the mere presence of Borrelia in vaginal and seminal secretions – if such an observation is indeed valid and can be confirmed independently – results in disease. In the absence of such proof, no conclusions can be drawn as to the sexual transmission of Lyme disease by of B. burgdorferi.

Addendum added in proof:

It should be noted that the basic epidemiology of vector-borne Lyme disease is strikingly different from that for sexually transmitted diseases (STDs). For example, annual data provided by the CDC indicate that about 95% of all reported cases of Lyme disease occur in 12 States, and the incidence of Lyme disease is seasonal and peaks with increased tick activity. Also, in the case of STDs, there are more husband-wife paired cases rather than the preponderance of cases of males and children with Lyme disease. Most important, Middelveen et al. state that “… the majority of our study subjects did not meet the positive standard as defined by the CDC surveillance criteria.” One must therefore wonder if their study subjects ever had Lyme disease in the first place.

References
Middleveen, MJ, Burke, J., Sapi, E., et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. [v1; ref status: awaiting peer review, http://f1000r.es/4rm] published 19 December 2014, F1000Research 2014, 3:309 (doi:10.12688/f1000 research.57778.1).

Moody, KD, and Barthold, SW. Relative infectivity of Borrelia burgdorferi in Lewis rats by varius routes of inoculation. Amer. J. Trop. Med. Hyg. 1991; 44: 135-139.

Woodrum, JE, and Oliver, JH Jr. Investigation of venereal, transplacental, and contact transmission of the Lyme disease sprirochete, Borrelia burgdorferi, in Syrian hamsters. J. Parasitol. 1999: 85, 426-430.

Wormser, GP, and O’Connell, S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert. Rev. Anti. Infect. Ther. 2011; 9: 245-260.

Williams, CL, Strobino, B, Weinstein, A. et al. Maternal Lyme disease; congenital malformations and a cord blood serosurvey in endemic and control areas. Paediatr. Perinat. Epidemiol. 1995; 180: 711-716.

Strobino, B, Abid, S, and Gewitz, M. Maternal Lyme disease and congential heart disease: a case control study in an endemic area. Am. J. Obstet. Gynecol. 199; 180: 711-716.

Elliot, DJ, Eppes, SC, and Klein, JD. Teratogen Update: Lyme disease. Teratology 2001; 64: 276-286.

http://www.cdc.gov/lyme/faq/#sexually
Competing Interests: No competing interests were disclosed. Close
Report a concern
Discussion is closed on this version, please comment on the latest version above.

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2	3	4
Version 3 (revision) 27 Apr 15		read	read	read
Version 2 (revision) 20 Jan 15		read	read
Version 1 18 Dec 14	read

Sam T. Donta, Falmouth Hospital, Falmouth, USA
Robert A Smith, University of Glasgow, Glasgow, UK
Monica E. Embers, Tulane University Health Sciences, Covington, USA
Nataliia Rudenko, Biology Centre Czech Academy of Sciences, České Budějovice, Czech Republic

Maryna Golovchenko, Biology Centre Czech Academy of Sciences, České Budějovice, Czech Republic

Comments on this article

All Comments(5)

Add a comment

Browse by related subjects

Back to all reports

Reviewer Report

84 Views

16 Jun 2017 | for Version 3

Nataliia Rudenko, Institute of Parasitology, Biology Centre Czech Academy of Sciences, České Budějovice, Czech Republic

Maryna Golovchenko, Institute of Parasitology, Biology Centre Czech Academy of Sciences, České Budějovice, Czech Republic

84 Views Cite this report Responses(0)

Approved

The third version of the paper from Middelveen et al., "Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions" represents a well designed and nicely executed study strongly supported by multiple results that were obtained by three independent laboratories. The impact of the presented data is significant as it highlights the alternative way of the distribution of the causative agent of Lyme disease, Borrelia burgdorferi sensu stricto spirochetes, rather than the traditionally accepted vector-borne way. The well balanced study presents the cultivation of live and replicating spirochetes from genital secretions, confirming the possibility of person-to-person transmission of Lyme disease spirochetes. Supported by multiple techniques, the obtained results are clear, consistent and confirming. The authors do not bring the conclusion or speculate that spirochetes transmitted from person-to-person might trigger Lyme disease in humans, as this postulation needs to be deeply studied. However, confirmation of the fact that live Borrelia are present in semen and vaginal secretions of patients with Lyme disease and can be cultured in active and replicating form from them is the first and significant step in analysis of person-to-person transmission of the causative agent of Lyme disease. This may be one of the reasonable explanations of the increased numbers of confirmed cases of Lyme disease worldwide, in addition to the others that are not discovered yet.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Not applicable
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

376 Views

11 May 2015 | for Version 3

Monica E. Embers, Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA, USA

376 Views Cite this report Responses(0)

Not Approved

My concerns have not necessarily been allayed by the authors' rebuttal.

Please be aware that I have invested as much time as I can in the review process for this article, and will be unable to contribute further.

Competing Interests

No competing interests were disclosed.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

228 Views

28 Apr 2015 | for Version 3

Robert A Smith, School of Life Sciences, University of Glasgow, Glasgow, UK

228 Views Cite this report Responses(0)

Approved

This current version of the paper is one which contributes significantly to the field. I re-affirm my original approval of what I consider is a well executed and well presented study and is worthy of indexation for rational scrutiny and further investigations by the wider medical and scientific communities.

Competing Interests

No competing interests were disclosed.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

394 Views

09 Apr 2015 | for Version 2

Monica E. Embers, Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA, USA

394 Views Cite this report Responses(1)

Not Approved

The design of these experiments to test the hypothesis that viable spirochetes exist in genital secretions is appropriate. However, the implementation of the experiments, presentation, and interpretation of data is questionable.

Culture of B. burgdorferi from secretions: These are not sterile sources, yet there is no mention of contamination with other microbes. The authors should show (supplemental data) staining of secretions and cultures from healthy controls. One would expect some level of background staining.

Images shown in Figures 1, 2 and 3 are not specifically detecting spirochetes and are questionable without appropriate controls. The darkfield and silver stain are of very little use, given that “pseudospirochetes” of flagellar bundles can forms in body fluid cultures. No positive or negative controls are shown. The straight morphology and varying lengths of that depicted in Figure 1A (and in all of the dataset 1 darkfield samples provided) are inconsistent with B. burgdorferi morphology. Specific staining shown in Fig 2A is more consistent with spirochete morphology and a legitimate detection method (albeit a low quality image). However, the authors indicate in the Methods section that DAPI counterstain was used but no blue staining is apparent. Does this mean that there were no other sources of DNA in the culture (bacteria or cells)? Clearly, there is ample contamination with other bacteria (seen in darkfield images of dataset 1). Concerning immunostaining with the FlaB probe, the methods are not described and no positive or negative control samples are shown. With the exception of Patient 10, none of the silver stained samples resemble spirochetes.

This reviewer encourages readers to examine the images provided in supplementary datasets.

Concerning the molecular detection, the sequence for the 23mer FlaB DNA probe should be provided, as should evidence of validation with controls. If multiple genes were amplified from cultures, then those sequences should also be provided. Assuming there was a positive control, 98-100% homology cannot distinguish between a legitimate infection and PCR contamination (with introduction of errors from PCR). Sequences from patients 10 and 11 as B. hermsii is misleading, given that they are short, disconnected regions of homology. Given that 16s was used, the entire product should line up. BLAST input was not provided for Patient 12 and the region of homology for patient 13 was only 50 bp (where for patient 1, 6 and 7 it was ~120 bp).

In conclusion, this manuscript would be made much clearer if all of the control (positive and negative) data were also included. Validation of the assays employed is unapparent. The paper cited from the Australian Biologics assay indicated PCR detection of Borrelia in patients at a much higher frequency than IgG or IgM immunoblot detection of exposure. This is inconsistent with multiple reports. Furthermore, the PCR primers are listed as “proprietary” so an assessment of specificity cannot be made. Sending blinded samples to an impartial 3rd party for testing using validated assays is recommended.

Competing Interests

No competing interests were disclosed.

Respond to this report

Responses (1)

Author Response

14 Apr 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

The design of these experiments to test the hypothesis that viable spirochetes exist in genital secretions is appropriate. However, the implementation of the experiments, presentation, and interpretation of data is questionable.

Culture of B. burgdorferi from secretions: These are not sterile sources, yet there is no mention of contamination with other microbes. The authors should show (supplemental data) staining of secretions and cultures from healthy controls. One would expect some level of background staining.

We acknowledge that these are not sterile sources. Three antibiotics were used to limit the growth of normal flora. Although Borrelia cultures may contain other flora, obtaining pure isolates was not the purpose of the study. The negative controls from healthy subjects did not show PCR evidence of spirochetal infection, as seen in Table 5 and Dataset 7. Real-time PCR failed to show spirochetal infection in genital cultures from negative controls (Table 5A), and both TaqMan PCR and nested PCR using a variety of targets failed to show Borrelia infection in genital cultures from negative controls (Table 5B). To address the referee’s concern about control silver staining and immunostaining, however, we have performed additional control silver stains and immunostains using a culture from uninfected mouse plasma, which showed no staining for Borrelia with either technique. Cultures of fungal-infected human skin, mixed gram positive strep and staph (from dairy mastitis cultures) and mixed gram negative fecal coliforms (from canine feces cultured on McConkey Agar) also failed to show significant immunostaining for Borrelia. In contrast, plasma culture from a mouse infected with Borrelia spirochetes processed at McClain Laboratory showed positive silver staining and immunostaining. We have included this information in Datasets 2A and 3A and added a description in the Results section on Pages 8 and 9.
Images shown in Figures 1, 2 and 3 are not specifically detecting spirochetes and are questionable without appropriate controls. The darkfield and silver stain are of very little use, given that “pseudospirochetes” of flagellar bundles can forms in body fluid cultures. No positive or negative controls are shown.

Figure 1 shows darkfield imaging and silver staining indicating that cultures are living and viable. The Figure shows typical spirochetal morphology, and these viable spirochetes were confirmed to be Borrelia by PCR, as shown in Table 5 and Dataset 7. Figure 2 shows immunostaining that is specific for Borrelia and correlates with positive PCR detection in these samples. Figure 3 shows molecular hybridization with the FlaB probe that is highly specific for Borrelia. The positive and negative controls for this experiment are shown in Supplemental Figure 1. Although each figure by itself might not indicate the presence of Borrelia, the combination of darkfield imaging, silver staining, immunostaining, PCR testing using a range of targets and molecular hybridization provides strong evidence for viable Borrelia in these genital cultures, as stated repeatedly in the article.
The straight morphology and varying lengths of that depicted in Figure 1A (and in all of the dataset 1 darkfield samples provided) are inconsistent with B. burgdorferi morphology.

We respectfully disagree with the referee, and we have included a discussion of morphological variation and pleomorphism in Borrelia cultures in the Discussion section on Page 16 with multiple references. Furthermore, to our knowledge nobody has ever studied Borrelia in seminal or vaginal cultures, so nobody knows what morphological variants would be present. Since Borrelia morphological variation and pleomorphism is acknowledged in the medical literature, visual identification alone is not reliable and that is why we used silver staining, immunostaining and molecular detection to characterize the isolates as Borrelia.
Specific staining shown in Fig 2A is more consistent with spirochete morphology and a legitimate detection method (albeit a low quality image). However, the authors indicate in the Methods section that DAPI counterstain was used but no blue staining is apparent. Does this mean that there were no other sources of DNA in the culture (bacteria or cells)? Clearly, there is ample contamination with other bacteria (seen in darkfield images of dataset 1).

We agree with the referee that immunostaining in Figure 2A is consistent with spirochete morphology. The DAPI counterstain was only used in the FlaB probe validation study, as shown in Supplemental Figure 1. We have modified the Methods description to reflect this fact.
Concerning immunostaining with the FlaB probe, the methods are not described and no positive or negative control samples are shown. Wth the exception of Patient 10, none of the silver stained samples resemble spirochetes.

The FlaB probe is a DNA probe, not an immunostain. This DNA hybridization technique is described in detail in Methods section 5 (Page 4) with appropriate references, and positive and negative controls for the technique are shown in Supplemental Figure 1. Again, we have included references to studies showing morphological variation and pleomorphism in Borrelia cultures in the Discussion section on Page 16. As there are problems with specificity of visual identification using silver staining, we used this method to provide corroborative evidence only. It is the collective evidence -- including darkfield imaging, immunostaining and molecular detection of borrelial DNA that is important. We used a broad approach with various methods so that there was no reliance on any single methodology, as stated repeatedly in the article.
This reviewer encourages readers to examine the images provided in supplementary datasets.

We encourage readers to do the same. The Dataset images support the findings described in the article.
Concerning the molecular detection, the sequence for the 23mer FlaB DNA probe should be provided, as should evidence of validation with controls.

We have provided the FlaB probe sequence in Methods section 5 (Page 4), courtesy of Dr. Alan MacDonald. Again, this is a molecular technique intended to provide corroborative evidence -- along with all the other techniques. A detailed vaildation study was provided in Supplemental Figure 1 clearly showing that the molecular probe was specific for Bb sensu stricto.
If multiple genes were amplified from cultures, then those sequences should also be provided. Assuming there was a positive control, 98-100% homology cannot distinguish between a legitimate infection and PCR contamination (with introduction of errors from PCR).

The gene sequences are described in Table 6, and BLAST analyses are shown in Dataset 6. The argument against PCR contamination is presented in the Discussion section on Page 17.
Sequences from patients 10 and 11 as B. hermsii is misleading, given that they are short, disconnected regions of homology. Given that 16s was used, the entire product should line up. BLAST input was not provided for Patient 12 and the region of homology for patient 13 was only 50 bp (where for patient 1, 6 and 7 it was ~120 bp).

The B. hermsii sequences are short, but they were the closest match in those samples. The referee ignores the fact that this couple was the only one with a distinct Borrelia sequence that was detected in both sexual partners and not in any other individual or couple in our small study. The BLAST analysis for Patient 12 was performed using a different program, and labeling for the sequence input has been provided. For Patient 13, the region of homology was short, but it was virtually identical to the sequence in her sexual partner (Patient 12), as shown in Table 6.
In conclusion, this manuscript would be made much clearer if all of the control (positive and negative) data were also included. Validation of the assays employed is unapparent. The paper cited from the Australian Biologics assay indicated PCR detection of Borrelia in patients at a much higher frequency than IgG or IgM immunoblot detection of exposure. This is inconsistent with multiple reports. Furthermore, the PCR primers are listed as “proprietary” so an assessment of specificity cannot be made. Sending blinded samples to an impartial 3rd party for testing using validated assays is recommended.

As outlined above, we have included control data for the PCR and molecular hybridization testing, which is the “acid test” for the presence of Borrelia in genital cultures. The assays described in our study are internally consistent since the darkfield imaging, silver staining and immunostaining have been validated by the PCR and molecular hybridization procedures. In contrast to the referee’s comment, there is ample evidence for “seronegative” Lyme disease, and we have included a discussion of this entity on Page 16 with appropriate references. We used two independent laboratories for PCR testing and molecular hybridization studies, and the results using a range of primers are consistent between the two laboratories. We intend to send blinded samples to independent laboratories for confirmation of our results. In light of our detailed responses to the referee comments, we believe that this preliminary study merits reconsideration for approval by the referee.

View more View less

Competing Interests

None

Back to all reports

Reviewer Report

182 Views

09 Mar 2015 | for Version 2

Robert A Smith, School of Life Sciences, University of Glasgow, Glasgow, UK

182 Views Cite this report Responses(0)

Approved

Middelveen et al. have, produced a well written and informative account of their findings on the “Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions” from subjects diagnosed as Lyme Disease patients by serological and clinical parameters compared to control individuals who were asymptomatic and serologically negative for the Borrelia burgodorfei. Of most interest is their report of the PCR sequencing of cultured spirochetes from three couples having unprotected sex which indicated that two couples had identical strains of Bb sensu stricto in their semen and vaginal secretions, while the third couple had identical strains of B. hermsii.
I believe the study is worthy of acceptance and approve it for the following reasons:

The rationale and hypothesis behind the investigation is clearly stated.
The work has been carefully planned, employing an array of pertinent experimental approaches: routine light microscopy, histological silver staining and immunohistological staining methodology, DNA probe analysis and PCR to demonstrate the presence of Borrelia spirochetes in cultures prepared from semen or vaginal secretions from Lyme disease subjects serologically tested for Bb, whilst samples from Bb negative control subjects did not yield spirochetes.
The study is well executed, with samples analysed following blind coding, and techniques performed in a number of independent laboratories.
The data sets, tables and figures are presented in a detailed and informative manner.
The authors demonstrate an authoritative awareness of previous work in the area, citing relevant animal studies which had investigated the possible sexual transmission of Borrelia, and give a plausible explanation for the discrepancies between the findings by Guftafson in dogs and those of Moody and Woodrun in inbred rodent models.
In this second version of the article, the authors have taken pains to address the main concerns of the reviewer Donta, and also answered the comments raised by Baker and others, to version one of the manuscript.
In their replies, Middelveen and Stricker have, in my opinion, more than allayed the criticisms with regard to technical details, and also those concerning aspects such as CDC surveillance criteria and of the unknown spirochetal load.
The conclusions drawn, that the culture of viable Borrelia spirochetes in human genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person, are justified and of significance. Their findings to date warrant a larger study and further attention by the scientific and medical community.

Competing Interests

No competing interests were disclosed.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

822 Views

05 Jan 2015 | for Version 1

Sam T. Donta, Falmouth Hospital, Falmouth, MA, USA

822 Views Cite this report Responses(1)

Not Approved

No evidence that samples were blinded.
The numbers of patients were too small from which to draw meaningful conclusions.
The actual serologic data on patients should be presented in order to be more properly assessed.
PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.
Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.
Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.
Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.
If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.
PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

Competing Interests

No competing interests were disclosed.

Respond to this report

Responses (1)

Author Response

20 Jan 2015

Raphael Stricker, International Lyme and Associated Diseases Society, Bethesda, 20827-1461, USA

Co-written with Marianne J. Middelveen

There are a number of issues that mitigate against the authors' conclusion that Lyme disease can be transmitted sexually.

We did not conclude that “Lyme disease can be transmitted sexually”. Based on preliminary editorial comments, we were careful to state that our microscopy, immunochemistry, molecular hybridization and PCR analysis showing live, culturable Borrelia in semen and vaginal secretions suggests that these spirochetes could be transmitted in that manner. Our study does not prove this form of transmission, and we do not make this claim anywhere in the text.
While there are conflicting reports from animal studies that there can be transmission by contact between animals and other studies that appear to better controlled that do not provide such evidence, there is no obvious epidemiological evidence in humans that this is a likely possibility. Apart from the sociologic implications of claiming that intimate or even casual transmission is possible, there needs to be more compelling evidence that this might be the case than is offered in this report.

The statement that “better controlled” studies do not provide support for contact transmission of Borrelia in animals is contrary to the examples in mice and dogs described in the Introduction and Discussion sections of our article. We have pointed out that the two studies on highly inbred rodents that allegedly showed lack of such transmission did not use PCR techniques and therefore may have missed this transmission. The fact that the CDC now admits to more than 300,000 new cases of Lyme disease each year in the USA (and perhaps as many as one million new cases, as outlined in Stricker & Johnson, 2014) is suggestive that other forms of transmission occur, as noted in the Discussion section on page 10.
1. No evidence that samples were blinded. 

In response to the referee’s comment, we have noted that the laboratory testing was performed on coded samples in a blinded fashion. This has been noted in the Abstract and reiterated throughout the Methods section.
2. The numbers of patients were too small from which to draw meaningful conclusions.

The “meaningful conclusions” are that  microscopy, immunochemistry, molecular hybridization and PCR analysis demonstrates live, culturable Borrelia in semen and vaginal secretions from Lyme disease patients. Although the numbers are relatively small, we feel that our detailed study supports this conclusion.
3.The actual serologic data on patients should be presented in order to be more properly assessed.

We can include the actual serologic data as an original Dataset, but we don’t see how that would alter the experimental findings in our study. The serologic data is presented in Table 1 and the Results section. In response to the referee’s comment, we have added more detail about the serologic and diagnostic criteria in the Methods section on page 4, with supporting references.
4. PCR-DNA analyses should have been done on the original specimens; again in a blinded fashion, and weekly during the culture period. And, as PCR-DNA testing is much more sensitive than cultures, without this information, the validity of the presented information remains in question.

PCR-DNA analysis was done on the “original specimens” in a blinded fashion  in conjunction with the microscopy, immunochemistry and molecular hybridization analysis. Repeated testing at weekly or other intervals is beyond the scope of this pilot study, and this type of testing should certainly be explored in future Lyme disease studies.
5. Concurrent samples of other body fluids, i.e. blood, saliva, should have been included.

As shown in Table 5, we did do PCR testing on concurrent blood samples in some patients. Saliva testing for Borrelia would have been of interest, but this form of Borrelia testing requires further investigation and is beyond the scope of our study. 
6. Even if presuming the presence of the Lyme borrelia in vaginal secretions or semen, the numbers present would have not been sufficient to cause any transmission of infection, as, with any infectious process, there needs to be a critical inoculum to establish infection. This is the case with transmission by ticks.

In response to the referee’s comment, we have researched the number of spirochetes necessary for transmission of B. burgdorferi infection in mice and T. pallidum  infection in humans. The results show that a very small number of spirochetes (as little as 18 organisms) are required for transmission of infection, and we have included this information in the Discussion on page 11. We have also noted that seminal plasma and the female genital tract may provide a relatively permissive environment for spirochetes compared to blood, skin and other immune sites, making transmission theoretically easier via the genital route.
Borrelia may be spirochetes as are Treponemes and Leptospira, but the transmission of the latter are obviously through body fluids, and not by tick or other vectors. It is not clear that infections transmitted by ticks are also transmitted by intimate or casual contact.

In response to the referee’s query, we have provided examples of other agents (Babesia, Chlamydia, Coxiella) that are proven or postulated to be transmitted by both tickbite and intimate contact. This information is included in the Discussion on page 11 with supporting references.
If it was true that 8/11 samples were positive, one would expect a much more obvious clinical picture of transmission by intimate or casual contact, which is not the case.

As noted above, the substantial numbers of  new Lyme disease cases each year suggests additional forms of transmission beyond a tickbite. At this time, the true epidemiology of Lyme disease is unknown because the CDC surveillance system only captures less than 10% of Lyme disease cases, as noted in the Discussion on page 11. Other epidemiological studies have suggested that some infected patients may be relatively asymptomatic (Harvey & Salvato, 2003), so transmission via intimate contact resulting in less obvious infection is plausible. The risk of this form of transmission and correlation with symptoms merits further study. Our report simply raises the possibility, and rejecting the report will shove this issue under the rug to the detriment of Lyme patients.
9. PCR-DNA analyses and long-term cultures can be subject to contamination, making the data here more difficult to interpret.

PCR-DNA analysis is subject to contamination. That is why we did blinded testing that always included negative controls in three different laboratories using microscopy, immunochemistry and molecular hybridization to confirm the PCR findings. Although PCR testing alone might be “difficult to interpret”, the combination of experimental techniques done in different laboratories makes interpretation much more reliable.

We hope that the referee will change his opinion after reading the revised manuscript and our responses to his comments.

View more View less

Competing Interests

No competing interests were disclosed.

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

Click here to access the data.

Downloaded data do not display as expected? Download the data

[1] Aberer E, Duray PH: Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods. J Clin Microbiol. 1991; 29(4): 764–72. PubMed Abstract | Free Full Text

[2] Bach G: Recovery of Lyme spirochetes by PCR in semen samples of previously diagnosed Lyme disease patients. International Scientific Conference on Lyme Disease. 2001. Reference Source

[3] Bankhead T, Chaconas G: The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol Microbiol. 2007; 65(6): 1547–58. PubMed Abstract | Publisher Full Text

[4] Barthold SW, Hodzic E, Imai DM, et al.: Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010; 54(2): 643–51. PubMed Abstract | Publisher Full Text | Free Full Text

[5] Brorson Ø, Brorson S, Scythes J, et al.: Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci U S A. 2009; 106(44): 18656–61. PubMed Abstract | Publisher Full Text | Free Full Text

[6] Burgdorfer W, Barbour AG, Hayes SF, et al.: Lyme disease- a tick-borne spirochetosis? Science. 1982; 216(4552): 1317–9. PubMed Abstract | Publisher Full Text

[7] Burgess EC: Experimental inoculation of mallard ducks (Anas platyrhynchos platyrhynchos) with Borrelia burgdorferi. J Wildl Dis. 1989; 25(1): 99–102. PubMed Abstract | Publisher Full Text

[8] Burgess EC: Experimentally induced infection of cats with Borrelia burgdorferi. Am J Vet Res. 1992; 53(9): 1507–11. PubMed Abstract

[9] Burgess EC, Amundson TE, Davis JP, et al.: Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am J Trop Med Hyg. 1986; 35(2): 355–9. PubMed Abstract

[10] Burgess EC, Patrican LA: Oral infection of Peromyscus maniculatus with Borrelia burgdorferi and subsequent transmission by Ixodes dammini. Am J Trop Med Hyg. 1987; 36(2): 402–7. PubMed Abstract

[11] CDC 2013. Press Release: CDC provides estimate of Americans diagnosed with Lyme disease each year. 2013. Reference Source

[12] CDC: Lyme disease: Laboratory testing. 2014a. Reference Source

[13] CDC: Lyme disease: 2011 case definition. 2014b. Reference Source

[14] Clark KL, Leydet B, Hartman S: Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci. 2013; 10(7): 915–31. PubMed Abstract | Publisher Full Text | Free Full Text

[15] Craig E: Is Lyme disease an STD? Outside Magazine. 2014. Reference Source

[16] Döpfer D, Anklam K, Mikheil D, et al.: Growth curves and morphology of three Treponema subtypes isolated from digital dermatitis in cattle. Vet J. 2012; 193(3): 685–93. PubMed Abstract | Publisher Full Text

[17] Gupta RS, Mahmood S, Adeolu S: A phylogenomic and molecular signature-based approach for characterization of the phylum Spirochaetes and its major clades: proposal for a taxonomic revision of the phylum. Front Microbiol. 2013; 4: 217. PubMed Abstract | Publisher Full Text | Free Full Text

[18] Gustafson JM: The in utero and seminal transmission of Borrelia burgdorferi in Canidae. 1993. PhD thesis, University of Wisconsin, Madison. 2014. Reference Source

[19] Harrison NA, Fitzgerald WR: Leptospirosis--can it be a sexually transmitted disease? Postgrad Med J. 1988; 64(748): 163–4. PubMed Abstract | Publisher Full Text | Free Full Text

[20] Harvey WT, Salvato P: ‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic? Med Hypotheses. 2003; 60(5): 742–59. PubMed Abstract | Publisher Full Text

[21] Ho EL, Lukehart SA: Syphilis: using modern approaches to understand an old disease. J Clin Invest. 2011; 121(12): 4584–92. PubMed Abstract | Publisher Full Text | Free Full Text

[22] Hodzic E, Imai D, Feng S, et al.: Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice. PLoS One. 2014; 9(1): e86907. PubMed Abstract | Publisher Full Text | Free Full Text

[23] Kumi-Diaka J, Harris O: Viability of Borrelia burgdorferi in stored semen. Br Vet J. 1995; 151(2): 221–4. PubMed Abstract | Publisher Full Text

[24] Kurtti TJ, Munderloh UG, Johnson RC, et al.: Colony formation and morphology in Borrelia burgdorferi. J Clin Microbiol. 1987; 25(11): 2054–8. PubMed Abstract | Free Full Text

[25] Lange R, Sayyedi S: Evidence of Lyme borreliosis infection from the viewpoint of laboratory medicine. Int J Med Microbiol. 2002; 291(Suppl 33): 120–4. PubMed Abstract | Publisher Full Text

[26] Maatouk I, Moutran R: History of syphilis: between poetry and medicine. J Sex Med. 2014; 11(1): 307–10. PubMed Abstract | Publisher Full Text

[27] Margos G, Hojgaard A, Lane RS, et al.: Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new Borrelia species, Borrelia kurtenbachii. Ticks Tick Borne Dis. 2010; 1(4): 151–8. PubMed Abstract | Publisher Full Text | Free Full Text

[28] Mayne PJ: Investigations of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue. Clin Cosmet Investig Dermatol. 2012; 5: 69–78. PubMed Abstract | Publisher Full Text | Free Full Text

[29] Mayne PJ: Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis and ehrlichiosis in an Australian cohort. Int J Gen Med. 2015; 8: 1–12.

[30] Menten-Dedoyart C, Faccinetto C, Golovchenko M, et al.: Neutrophil extracellular traps entrap and kill Borrelia burgdorferi sensu stricto spirochetes and are not affected by Ixodes ricinus tick saliva. J Immunol. 2012; 189(11): 5393–5401. PubMed Abstract | Publisher Full Text

[31] Middelveen MJ, Mayne PJ, Kahn DG, et al.: Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013a; 6: 1–21. PubMed Abstract | Publisher Full Text | Free Full Text

[32] Middelveen MJ, Burugu D, Poruri A, et al.: Association of spirochetal infection with Morgellons disease [v1; ref status: indexed, http://f1000r.es/8g]. F1000Res. 2013b; 2: 25. PubMed Abstract | Publisher Full Text | Free Full Text

[33] Middelveen MJ, McClain SA, Bandoski C, et al.: Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report. Res Open Access. 2014a; 1: 875. Publisher Full Text

[34] Middelveen MJ, Burke J, Sapi E, et al.: Raw data of Borrelia spirochetes in human vaginal and seminal secretions. F1000Research. 2014b. Data Source

[35] Moody KD, Barthold SW: Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Amer J Trop Med Hyg. 1991; 44(2): 135–9. PubMed Abstract

[36] Mursic VP, Wanner G, Reinhardt S, et al.: Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection. 1996; 24(3): 218–26. PubMed Abstract | Publisher Full Text

[37] Nolte O: Nucleic Acid Amplification Based Diagnostic of Lyme (Neuro-)borreliosis - Lost in the Jungle of Methods, Targets, and Assays? Open Neurol J. 2012: 6(Suppl 1–M7): 129–139. PubMed Abstract | Publisher Full Text | Free Full Text

[38] O’Rourke M, Traweger A, Lusa L, et al.: Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One. 2013; 8(5): e63968. PubMed Abstract | Publisher Full Text | Free Full Text

[39] Pathak S, Lau YF, Drwinga HL: Observations on the synaptonemal complex in Armenian hamster spermatocytes by light microscopy. Chromosoma. 1979; 73(1): 53–60. PubMed Abstract | Publisher Full Text

[40] Sapi E, Pabbati N, Datar A, et al.: Improved culture conditions for the growth and detection of Borrelia from human serum. Int J Med Sci. 2013; 10(4): 362–76. PubMed Abstract | Publisher Full Text | Free Full Text

[41] Schmidt BL: PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev. 1997; 10(1): 185–201. PubMed Abstract | Free Full Text

[42] Schmid M, Müller H, Stasch S, et al.: Silver staining of nucleolus organizer regions during human spermatogenesis. Hum Genet. 1983; 64(4): 363–70. PubMed Abstract | Publisher Full Text

[43] Shaw GM, Hunter E: HIV transmission. Cold Spring Harb Perspect Med. 2012; 2(11): a006965. PubMed Abstract | Publisher Full Text | Free Full Text

[44] Stricker RB, Johnson L: Lyme disease: Call for a “Manhattan Project” to combat the epidemic. PLoS Pathog. 2014; 10(1): e1003796. PubMed Abstract | Publisher Full Text | Free Full Text

[45] Stricker RB, Moore DH, Winger EE: Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact. J Investig Med. 2004; 52: S151.

[46] Woodrum JE, Oliver JH Jr: Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol. 1999; 85(3): 426–30. PubMed Abstract | Publisher Full Text

[47] Wright SD, Nielsen SW: Experimental infection of the white-footed mouse with Borrelia burgdorferi. Am J Vet Res. 1990; 51(12): 1980–7. PubMed Abstract

[48] Yang J, Liu Z, Guan G, et al.: Evaluation of molecular methods for detection of Borrelia burgdorferi senso lato in ticks. Diagn Microbiol Infect Dis. 2012; 73(1): 80–3. PubMed Abstract | Publisher Full Text

Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions

Abstract

Keywords

Introduction

Materials and methods

1. Research subject selection

2. Borrelia cultures

3. Dieterle silver staining

4. Anti-Bb immunostaining

5. Molecular hybridization using Bb DNA probe

6. PCR of cultures

Results

1. Patient data

Table 1. Patient Data.

2. Light and darkfield microscopy

Table 2. Microscopy results from fresh blood and genital culture fluid.

Figure 1.

Table 3. Microscopy results and Dieterle silver staining of genital culture concentrates.

3. Immunohistochemistry

Table 4. Results of B. burgdorferi immunostaining and FlaB molecular hybridization in genital culture concentrates.

Figure 2.

4. Molecular hybridization

Figure 3.

5. PCR testing

Table 5. A: Real time PCR testing of genital culture concentrates performed by Australian Biologics. ND, not done. See Dataset, data file 5. B: Real time and nested PCR testing of blood and genital culture concentrates performed by University of New Haven. See Dataset, data file 7. ND, not done.

6. Sequencing of Borrelia detected in blood and genital cultures

Table 6. Comparison of seminal and vaginal Borrelia gene sequences using BLAST analysis.

Discussion

Data availability

Consent

Author contributions

Competing interests

Grant information

Acknowledgements

Supplementary material

Supplemental figure 1. Molecular hybridization of FlaB probe with Borrelia strains, T. denticola and E.coli.

References

Comments on this article Comments (5)

Open Peer Review

Comments on this article Comments (5)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

The problem

How to fix it

Competing Interests Policy

Stay Updated